Upcoming Events


FDA

Biotech Boom

Massachusetts
Life Sciences Innovation Day 2014

 
Date:
Tuesday, June 3rd, 2014
Description:
Time: 8:00 AM - 7:00 PM
Harvard Club of Boston, 374 Commonwealth Avenue, Boston

The 7th Massachusetts Life Sciences Innovation (MALSI) Day  is the biggest day for life sciences startups and innovation in the Commonwealth of Massachusetts. This is a high-energy, hands-on event which brings together scientific leaders and business experts to mingle with scientists, post-docs, professors, entrepreneurs, innovators, and venture capitalists.

Can you still be creative? In every lab in every research institution and company, researchers are told that they should be creative.  But can researchers still be creative with the organizational and financial demands that are placed on research environments?  Do corporations and academics still have the courage to allow their teams to be really creative? If you want to do interesting and exciting science can you still get the funding? How does business and finance leadership view creativity? Our speakers and panelists will discuss the current battle to create innovation friendly environments and its impact on entrepreneurs and young researchers finding jobs.

The conference will feature Keynotes, Panels, Innovators' Marketplace, Networking Reception with leading life sciences CEO's , and Poster Competition - great prizes for 3 best posters!


Join us for the flagship event of life sciences in Massachusetts, jointly and actively put together by all the major organizations that are involved in starting and supporting the life sciences start-up ecosystem in the Commonwealth.

 

What people said about last year's event

 

"The MALSI Day was more than a well-thought-out event-it was an introduction to the entire Life Sciences ecosystem in our region!  As a newcomer to Boston, this was the single most-helpful conference I attended this year.   Everyone you could ever hope to meet in this space was literally in the same room, sharing their viewpoints on opportunities and challenges, and calling on us all to participate and continue to build this amazing community."

"The conference was an excellent opportunity to network simultaneously with entrepreneurs, academics, and seasoned business leaders."
"...I met with 2 Harvard Post docs that were attending [who] had been mulling an idea for a new startup company but have been hesitant to really talk about it or move forward because they were not ready? [T]hey said that after this meeting that they felt much more confident to actually move forward and will start the process of kicking things off."

"It was fun and most informative. I met some great people, thinkers and continued to expand/deepen my knowledge on life science, innovation and tech transfer. You all did a fantastic job of putting this event together."

"I thought the event was personally very beneficial from a networking perspective since I was presenting a poster and able to speak with both investors and potential partners. ?the Harvard club is beautiful and a nice historical nod to Boston." 

 

Conference Fees:

  • $200 Academics/staff at MATTO member institutions and Members of MassBio
  • $250 Non-members
  • $60 Students and post-docs (ID's will be required at the event)
  • $550 Innovators' Marketplace Exhibitor* (includes two attendees for a full day conference). Please register on-line the first Exhibitor and send the transaction number and the name and email address of the second Exhibitor to jgoldberg@umassp.edu
  • $80 Reception only  - includes poster competition, CEO Reception and Innovators' Marketplace (5-7 pm only)

*Professional Service Providers (Lawyers, accountants, consultants etc) will ONLY  be allocated space in the exhibit hall if they sponsor the conference - for a listing of sponsorship opportunities please visit our Sponsorship page.

 

Registration

On-line registration is open.


About MALSI

Massachusetts Life Sciences Innovation Day has been developed by the Massachusetts Life Sciences Start-up Initiative (MALSI). MALSI is a platform organization that brings together all major public and private entities in the State that are committed to building the next generation of Massachusetts companies. MALSI's mission is to ensure that Massachusetts maintains its lead as the #1 region in the world to start, nurture and grow life sciences companies.
MALSI partners include: Massachusetts Technology Transfer Center, MassBio, Mass Medical Angels, TiE Boston, and several major universities and research hospitals.



Harvard Biotech Club's Career Fair 2013
Date:
Monday, September 30th, 2013,
1:00 - 5:00 PM
Venue:
New Research Building (3rd floor Rotunda), Harvard Medical School, 77 Avenue Louis     Pasteur, Boston

(Google Map)

 

See our Career Fair website


Past Events


Fall 2013 Healthcare Innovation and Commercialization Course (HIC)

Description


Healthcare Innovation & Commercialization (HIC) is a 10-week, non-credit Harvard Medical School course created with the goal of helping MDs, PhDs, and Post-docs to succeed in life sciences entrepreneurship and medical innovation. TheHIC course will meet one evening per week and run from early September through mid-November. Students learn about industry trends in the life sciences, regulatory and reimbursement issues, health policy, startups and startup financing, venture capital, licensing, and technology transfer (from academia to business).   HIC is taught by accomplished entrepreneurs, venture capitalists, corporate executives, and consultants who have been involved with the commercialization of healthcare-oriented technologies.  Throughout the course, students will work in teams to develop business plan pitches for real early-stage technologies originating from within the Harvard research community. Teams are mentored by seasoned entrepreneurs, and the final pitches are adjudicated by real VCs and industry experts, who provide valuable feedback.

Highlights:

*             Step-by-step, class-by-class teaching of the nuts & bolts of building business plans

*             Work with real-life inventions at Harvard

*             Mentors assist in guiding the preparation of business plans

*             Many expert panel discussions allow for building networks

*             Collaboration with the Harvard Innovation Lab

REGISTRATION INFORMATION:  Registration for the course will open on Friday, 8/16 and close on Monday, 8/26.  TO REGISTER, PLEASE VISIT: https://sites.google.com/site/hicfall2013  (THE COURSE WEB SITE WILL GO LIVE ON 08/16/2013)
QUESTIONS?  email  hic.2013.harvard@gmail.com<mailto:hic.2013.harvard@gmail.com>
HIC is generously sponsored by Goodwin Procter, the Harvard Biotechnology Club, and the DMS Paths Program


McKinsey & Company/Harvard Biotech Club Healthcare Consulting Presentation
Date
August 28   5:30 -7:30 PM
Venue
Tosteson Medical Education Center (TMEC) Room 227,  260 Longwood Avenue, Boston
Description
Learn about some of McKinsey's high impact healthcare consulting work at this event.
Snacks and refreshments will be served.
An RSVP is required; reply to   http://www.surveymonkey.com/s/2013McKBiotechHealthcareEvent




Patent Law Career Panel Discussion 2013
Date: Thursday, August 22, 2013
Venue: Ballard Room, Countway library 5th floor, Longwood Medical Area

Description:

The DMS Law Path, in collaboration with the GSAS Harvard Biotech Club, will be hosting a Patent Law career panel discussion.  The panel will consist of five DMS alumni who are now technology specialists and patent lawyers.

Panelists:
Nathan Billings, PhD, Patent Agent, Choate Hall & Stewart LLP
Heather diPietrantonio, PhD, Patent Agent, Wolf Greenfield
Jeffrey Kessler, PhD, JD, Associate, Clark & Elbing LLP
Edmund Koundakjian, PhD, Patent Agent, Edwards Wildman Palmer LLP
Jing Wang, PhD, JD, Associate, Cooley LLP
 
Pizza will be provided at 5:45 pm.

Please RSVP here by 8/15 if you plan on attending, so we can have enough food for everyone.

Mass Life Sciences Innovation Day (MALSI) 2013
Date:   Wed, June 5 2013
Description:

Time: 8 am - 7 pm

Venue: Harvard Club of Boston, 374 Commonwealth Avenue, Boston

 

Business as Usual or Brave New World?    

 

The 6th Massachusetts Life Sciences Innovation (MALSI) Day  is the biggest day for life sciences startups and innovation in the Commonwealth of Massachusetts. This is a high-energy, hands-on event which brings together scientific leaders and business experts to mingle with scientists, post-docs, professors, entrepreneurs, innovators, and venture capitalists.

Business as Usual or Brave New World?
  Can we learn valuable lessons from life sciences start-up companies that have already been formed and funded? Or are life sciences entrepreneurs entering a "Brave New World" where their path to success is going to be completely different?  Our speakers and panelists will consider the current status life sciences and what changes we should expect in the future.  How will these changes impact basic research, technology commercialization, investment in new companies, and scientists' careers?
 
For more information and to register, please see
 http://www.mattcenter.org/malsi-day-2013/home.html 
 

 

Panels and Open Discussions will include:
  • Getting to First Base - our panel of CEOs will talk about how they raised new funding in the last 12 months
  • 7 habits of extraordinarily successful life sciences companies - what habits have made some start-ups successful in the past and will these traits still be relevant in the future  
  • What will the Academic-Industrial Complex look like in the next decade?  
  • Which business models will still be relevant in the next five years?  
  • You want to continue to have a career in science - but what will that be like in academia or in industry  
  • Are Virtual Companies Faster, Better and Cheaper?
  • What will the founding teams of start-ups look like - experienced teams or student entrepreneurs?     

 

Plenary "7 Habits of Extraordinarily Successful  Life Sciences Company" by Abbie Celniker, CEO, Eleven Biotherapeutics

  

Panelists and Moderators will include:    

  • Irene Abrams, Director, Research Ventures & Licensing, Partners Healthcare   
  • Jon Behr, Vice President, New Ventures, Enlight Biosciences   
  • Jeff Behrens, President & CEO, Sialix, Inc.  
  • Kevin Bitterman, Principal, Polaris Partners  
  • Nancy Briefs, CEO, InfoBionic
  • John Brooks, CEO, Joslin Diabetes Center
  • Lauren Celano, Founder and CEO, Propel Careers
  • David Cohen, Director of Hepatology, Brigham & Women's Hospital  
  • Cliff Culver, Founder, OnDeckBiotech
  • Bill Edelman, Chairman at Large
  • Jose-Maria Fernandez, Researcher, MIT Sloan School of Management 
  • Johannes Fruehauf, CEO, LabCentral
  • Carolyn Green, President and Director, Atreaon Inc.
  • Scott Kennedy, Vice President of Translational Medicine-Global, Novartis
  • Ankit Mahadevia, Principal, Atlas Venture  
  • Albine Martin, COO, Precision Biologics, Inc
  • Sanjeev Munshi, Director, Business Development, Merck  
  • Auro Nair, General Manager, Scientific Research Services, Jackson Laboratory
  • Mark Namchuk, Senior VP of Research for North America, Vertex   
  • Aaron Sandoski, Managing Director, Norwich Ventures  
  • Michael Schrader, CEO, Vaxess  
  • Josh Tolkoff, Partner, Ironwood Equity  
  • Mike Travis, Principal, Travis & Company, Inc.      

 

The conference will feature Innovators' Marketplace - the one-stop-shop to find everything to start a company and meet companies who will help engineer and design drugs and devices, Networking Reception, and  Poster Competition

 

 
CONFERENCE FEES
  • $190 Academics/staff at MATTO member institutions and Members of MassBio
  • $235 Non-members
  • $60 Students and post-docs (ID's will be required at the event)
  • $550  Innovators' Marketplace Exhibitor (includes two attendees). Service providers will only be allocated space in the exhibit hall if they sponsor the conference - for a listing of sponsorship opportunities please visit our Sponsorship page.
  • $75 Reception only  - includes poster competition, CEO Reception and Innovators' Marketplace (5-7 pm only)

Register button

 

FOR SPONSORSHIP OPPORTUNITIES

Contact:     Abi Barrow, MTTC, at abarrow@umassp.edu

 

 
Feedback from last year MALSI Day 2012:

MALSI 2012
" ...This is one of the most worthwhile 1-day events I go to."
"...Format of Open Discussions was a good way to encourage conversation and questions."
"...Absolutely great conference. I think it's now the best emerging life science
conference on the East Coast all year."
"...The event was fantastic including top speakers, participants and the agenda." 
 
 

 

Meet Third Rock Ventures
Date:   Wed, May 15, 5.00 - 7.00 PM
Description:

Cannon Room, 1st floor Building C, Harvard Medical School, 240 Longwood Ave, Boston

 

Third Rock Ventures (TRV) is a premier life sciences venture capital firm. With over $1.3 Billion raised since it started in 2007, Third Rock Ventures has assembled an entrepreneurial team with deep expertise and a proven track record of building some of the most respected and successful life sciences companies. Come and meet with representatives from Third Rock Ventures and learn how you can be part of their success story.

 

Dinner will be provided to RSVPs. Please RSVP to rsvp@thebiotechclub.org

 

 

 

Sachs Associates Boston 2013

Dear Member,

Harvard Biotech Club has recently become a supporter of the upcoming event organised by Sachs Associates who have allocated limited amount of complimentary conference passes for students & academics. Other members will be offered a special discounted rate for either attending or presenting at the event.

TO REGISTER OR EXPRESS INTEREST AND RECEIVE
YOUR PERSONAL OFFER PLEASE FOLLOW THE LINK
AND SUBMIT THE FORM ONLINE

The Sachs Cancer Bio Partnering Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering and investment.  There are 9 panels plus Keynote Speeches in the plenary session. In addition, there is a presenting company track where companies can present to an audience of financial and industry investors. This would include both listed and venture backed companies. We expect around 300 delegates. There is an online meeting system with meeting facilities to make the event fully transactional. The conference is free to accredited financial investors.

WHY ATTEND?

Cutting Edge Program including Keynote Speeches made by:

  Alykhan Shamji Dr Susan Love Dr David Heimbrook Prof Edward Benz Lynda Chin
  Alykhan Shamji Dr Susan Love Dr David Heimbrook Prof. Edward Benz Lynda Chin

 

Topics covered in the forum include:
• Big Pharma Approach to Innovation
• Cancer Stem Cells
• Cancer Tech – Device, Diagnostics & Image Technologies
• Deal Making and Investment
• Immunotherapies & Cancer Vaccines
• Israel Bio-Med
• NextGen Targeted Therapies
• Public-Private Partnerships
• Translational Research – Advances & Directions

Confirmed Speakers & Chairs include:
• Anne Altmeyer, Vice President, Business Development & Licensing, Novartis
Armen Shanafelt, Venture Partner, Lilly Ventures
Aya Jakobovits, Venture Partner, Orbimed Israel
Beth Jacobs, Managing Director, Excellentia Global Partners
Darryl Mitteldorf, Executive Director, Global Prostate Cancer Alliance
David Allan, Executive Chairman, Stem Cell Therapeutics (SCT)
Dennis Purcell, Senior Managing Director, Aisling Capital
• To view all please click HERE

Confirmed Presenting Companies include:
• Argos Therapeutics
• CureVac GmbH
• Epizyme
• MacroGenics, Inc.
• MolecularMD
• Zyngenia, Inc
• To view more – click HERE


Warm Regards

The Sachs Associates Team
27 Belsize Lane, London NW3 5AS
Tel: +44 (0)203 463 4890 • Fax: +44 (0)207 691 7919 • www.SachsForum.com

To UNSUBSCRIBE click HERE

Sponsored and suported by:
Sachs Boston 13 Supporters and Sponsors
Regional Partners:
Sachs Boston 13 Regional Partners
Pharma Licensing Groups represented on the program:
Sachs Boston 13 Phrama Licensing Groups

 

Flagship Ventures Entrepreneurial Fellows Program Discussion
Date:   Mon, Mar 18, 5.30 - 7.30 PM
Description:

Cannon Room, 1st floor Building C, Harvard Medical School, 240 Longwood Ave, Boston

 

The Flagship VentureLabs team is coming to the Harvard Biotech Club to discuss the    VentureLabs Entrepreneurial Fellows Program. Flagship VentureLabs is a unit of Flagship Ventures which invents and launches transformative companies.

 

VentureLabs conducts an annual summer Entrepreneurial Fellows Program which provides an opportunity for talented graduating students (MBA, MS, PhD, MD, etc.) and current postdocs to gain hands-on experience in Flagship VentureLabs' unique approach to company conception, innovation and entrepreneuring. Please join us to learn more about this exciting opportunity and network with VentureLabs team members following the discussion.
 

Dinner will be provided. Please RSVP to thebiotechclub.rsvp@gmail.com.


www.flagshipventures.com/venturelabs/fellows-program

 

Lunch Panel on Business Industries with

Harvard Business School Career Coaches

Date:   Mon, Mar 4, 12-1 PM
Description:

Bray Room, 1st floor New Research Building (next to cafeteria), Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map) 

 

Co-hosted by the Harvard Graduate Business Club and the Harvard Biotech Club
 

Come have lunch at the NRB this coming Monday! We have a lunch panel on business careers by coaches from the Business School.

Have you thought about a career in business, but are not sure where your skills from graduate school fit best? Join senior career coaches from the Harvard Business School for a panel to chat about opportunities in business and the many facets of business careers.

Coffee and desserts will be provided.

 

Talk by Biotech Journalist Adam Feuerstein:

"Identifying Biotechs that may be Headed for a Takeoff...or a Crash Landing:

Lessons for New Investors"

Date:   Tue, Dec 11, 6-7 PM
Description:

Bray Room, 1st floor New Research Building (next to cafeteria), Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map) 

 

We are honored to have invited Adam Feuerstein, senior columnist at TheStreet and one of today's top biotechnology journalists to speak to us at the Harvard Biotech Club (http://www.fiercebiotech.com/special-reports/fiercebiotechs-top-writers-biotech). 

Are you interested in the world of biotech companies and biotech stocks, R&D, clinical trials, and how CEOs manage their companies? From the perspective of one of the most controversial and respected biotech journalists of our times? Join us to learn more! We will start with a 30min talk by Adam, followed by a 30min Q&A session opened to the audience. 

Read more about Adam Feuerstein on his blog here: http://www.thestreet.com/topic/45381/adam-feuersteins-biotech-blog.html

Please RSVP to thebiotechclub.rsvp@gmail.com.

 

HIV Competitive Landscape - from science to bedside to biotech

Date:   Mon, Nov 19, 4-5 PM
Description:

Cannon Room, Building C, HMS Quad

Dinner reception following, 5-6 PM    
 

 

What are the driving factors shaping current drugs for curing HIV? Join us to learn insider secrets on the interplay between scientific ideas, R&D, market dynamics, and the clinical needs of patients.

 

Dr. Peter Kolchinsky, Managing Director of the investment fund RA Capital, will first present a detailed review of the current and future therapeutic landscape surrounding HIV and chronic disease management.      

A panel of HIV experts from Harvard, including Prof. Daniel Kuritzkes, Prof. Todd Allen and Dr. Mohammed Asmal, will then lend their insights into this rapidly evolving therapeutic arena and discuss their personal outlooks for the future treatment of HIV infection. The discussion will address the current status of all fronts in the HIV battle including prevention, management and curing the disease.  The panel will explore the competitive landscape shaping chronic disease management as well as provide an in depth analysis of the most exciting therapies in development by biotech companies that promise a cure.    

An RSVP is required: thebiotechclub.rsvp@gmail.com

 

Presented by

 

Peter Kolchinsky, Ph.D.

Managing Director - RA Capital

 

Panel Discussion

 

Daniel Kuritzkes, MD

Professor of Medicine - Infectious Disease
Brigham & Women's Hospital

 

Todd Allen, Ph.D.

Associate Professor at Ragon Institute of MGH, MIT and Harvard

Massachusetts General Hospital

 

Mohammed Asmal, MD, Ph.D.

Associate Medical Director at Vertex Pharmaceuticals

Instructor at Harvard Medical School

 

 

 

Smooth Transitions: The Top 10 Questions Scientists Ask about Finding an Industry Job

Date:   Tue, Nov 13, 5-6 PM
Description:

Cannon Room, Building C, HMS Quad

Dinner reception following, 6-7 PM

 

This event will be a one-hour presentation by Dr. Joanne Kamens (see bio below) with detailed tips, resources and ideas for being successful in a career transition to industry, followed by a reception. These days, staying in academia is really the “alternative” career for scientists. The majority of young scientists will not end up in a traditional academic research position.  This presentation will give you some criteria to consider in deciding if embarking on an industry science career is right for you and then will provide concrete tools and resources for preparing for this transition.
 

An RSVP is required: https://docs.google.com/spreadsheet/viewform?formkey=dGt5OG5RbkFBTmxwQjJoSndtcmlNSHc6MQ


Questions? Please contact Anna Turetsky at turetsky@fas.harvard.edu

 

Speaker Bio:
Joanne Kamens, PhD
Executive Director, Addgene
Dr. Kamens received her PhD in Genetics from Harvard Medical School then spent 15 years at BASF/Abbott where she led discovery research projects on small molecule and antibody approaches to inflammatory diseases, ultimately serving as Group Leader in Molecular Biology. In 2007 she joined RXi Pharmaceuticals as Director of Discovery and concluded there as Senior Director of Research Collaborations. In 2011, Dr. Kamens became the Executive Director of Addgene, a mission driven, non-profit dedicated to helping scientists around the world collaborate. She has been raising awareness of women scientists since 1998 upon realizing that an entire week had gone by at work and not one other woman had been at any meeting she attended. Dr. Kamens founded the Boston chapter of AWIS and serves as a Director at large for the Healthcare Businesswomen’s Association Boston Chapter. Follow her on Twitter: @jkamens www.linkedin.com/in/joannekamens

 

   

Making the Most of the Harvard Biotechnology Club's Career Fair:

Resumes and Networking Strategies

Date:   Thur, September 13 2012
Description:

Time: 2:30 - 4:00 PM

Venue: Cannon Room, 1st Floor Building C, Harvard Medical School Quad.

 

Are you attending the Harvard Biotech Career Fair on Sep 25? Make the most out of this great opportunity to meet with employers who want to hire PhDs!

Laura Stark Malisheski of the Office of Career Services for Harvard's Faculty of Arts and Sciences, will share her tips on how to present yourself, on paper and in person!

In the first part of this workshop, you will learn how to best organize your resume for different types of PhD-level nonacademic positions. Laura will offer specific guidelines and sample resumes to inspire you to create a resume that best represents your strengths and experiences.

In part two of the workshop, you will learn how to effectively introduce yourself to potential employers and make the most of your time at the HBC Career Fair.

RSVP: If you would like to attend this event, please send an email to RSVP@thebiotechclub.org with "workshop" in the subject line.

Presented to you by the GSAS Harvard Biotech Club in collaboration with the Harvard FAS Office of Career Services

 

Harvard Biotech Career Fair 2012
Date: Tue, Sep 25, 2012
Description:

Time:   1.00 - 5.00PM

Venue: 3rd Floor Rotunda, New Research Building, Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map)

 

See our Career Fair website

 

Symposium on Scientist-Entrepreneurs in Harvard
Date:   Tues, July 17 2012
Description:

Time: 5:00 - 7:00pm

Change in Venue: Cannon Room, Building C, HMS Quad

 

Have you ever dreamed of turning your scientific research into life-saving drugs some day? Are you a scientist who is aspiring to make a break into entrepreneurship? Do you want to create or be involved in your own biotech startup? Come join the Harvard Biotech Club for a symposium on this amazing career trajectory. Take this opportunity to learn from and network with 3 leading scientist-entrepreneurs in Harvard Medical School.

 

Dr. David Sinclair, Professor of Genetics at Harvard Medical School, Venture Partner at Lux Capital, and co-founder of Sirtris (acquired by GSK for $720M in 2008), Genocea, and now OvaScience.

 

Dr. Chiang J. Li, Founder, Chairman, Chief Executive Officer, and Chief Medical Officer of Boston Biomedical - recently acquired by Dainippon Sumitomo with an upfront payment of $200M and potential milestone payments totalling up to $2.6B. He also serves as co-Director of the Skip Ackerman Center for Molecular Therapeutics at Beth Israel Deaconess Medical Center, Harvard Medical School. Formerly, Dr. Li was the Chief Scientific Officer & Executive Vice President of ArQule. He has also served as co-founder of Cyclis Pharma (acquired), ArQule Oncology (Nasdaq:arql), and Cequent Pharma (acquired). Dr. Li has over 60 inventions and has translated a number of his medical innovations to patients for the treatment of cancer, and other life threatening disorders.

 

Dr. Gregory Verdine, Professor of Chemistry at Harvard University, Venture Partner at Third Rock Ventures, and co-founder of Gloucester, Enanta, Tokai, Aileron, Eleven Bio, ONTorii, and now WarpDrive Bio (launched in 2012 with $125M in financing).

 

This event is open to all Harvard-affiliated students and postdocs. Pizza will be served. Please RSVP to thebiotechclub.rsvp@gmail.com with the title "scientist-entrepreneurs".

 

Healthcare Consulting Panel
Date:   Thurs, July 19th 2012
Description:

Time: 6.00 - 8.00 PM

Venue: Cannon Room, Bldg C, Harvard Medical School, 240 Longwood Ave, Boston MA 02115

 

Are you interested in a career in consulting, and want to know what consultants actually do and what their life is like? Or will you be on job market soon and would like to know how to be competitive in applying for consulting jobs? If you are either of the above, this is a wonderful opportunity for you! 

Come join us for a consulting panel discussion this summer. Take this opportunity to talk to consulting professionals from 5 leading firms during the networking session.

Companies participating:

 

McKinsey & company

BCG

Clarion Healthcare

ClearView Healthcare Partners

Decision Resources

 

This event is open to all Harvard- affiliated students and postdocs. Food will be served. Please RSVP to thebiotechclub.rsvp@gmail.com with the title "rsvp for consulting panel".

 

Massachusetts Life Sciences Innovation Day 2012
Date:   Wed, May 30 2012
Description:

Time: 8 am - 7 pm

Venue: Harvard Club of Boston, 374 Commonwealth Avenue, Boston

 

The 5th Massachusetts Life Sciences Innovation (MALSI) Day is the biggest day for life sciences startups and innovation in the Commonwealth of Massachusetts. This is a high-energy, hands-on event which brings together scientific leaders and business experts to mingle with innovators, post-docs, professors, entrepreneurs, innovators, and venture capitalists.

Participate at  Panels and Open Discussions that will include: 

  •  "What does your data show  - what is publishable vs. what is commercializable"
  • "Getting other people to prove it for you"
  • "Proof of Concept Experiments"
  • "Showing the market exists"  

 

May 30, 2012 8:00 a.m. - 7:00 p.m.
Harvard Club of Boston, 374 Commonwealth Avenue, Boston

 http://www.mattcenter.org/malsi-day-2012/home.html

 

EMERGING TECHNOLOGY POSTER SESSION

The Search for Proof Poster Competition - great prizes for 3 best posters!

A key goal of the event is an exchange of ideas, to connect the broader scientific community with those working in finance and policy.  The earliest insight can, in time, foster an entire industry.

Our poster session will showcase fundamental advances in research so they can be seen by a broader audience, to help set the compass for where the industry could go in the future.

 

To reflect the Conference theme "Burden of proof" presenters can include in their posters what has already been proven and what needs to be proven.

 

If your lab or company has notable discoveries or new grant awards that you want to publicize to the Massachusetts research and business communities please download the application to exhibit a poster and submit it to jgoldberg@umassp.edu by (NOTE DEADLINE EXTENSION) May 22, 2012.

 

Historical Case Study of Athersys (ATHX) with biotech hedge fund RA Capital
Date:   Thurs, May 24 2012
Description:

Time: 5:30-8:30pm

Venue: TBA only to RSVPs

 

We are very fortunate to have invited Dr. Peter Kolchinsky, Managing Director, TechAtlas and RA Capital Management, and Mr. Rajeev Shah, Partner, RA Capital Management, to come teach us the thought processes that went into the analysis of a biotech firm's competitive landscape. Come see how its done from the perspective of two very seasoned and successful biotech hedge fund managers. We will do this with a case study on Athersys, a biotech which terminated its obesity drug program to bring forward its mesenchymal stem cell program, in comparison to Arena (obesity drug competitor), Mesoblast and Osiris (stem cell competitors).

 

"...be prepared for a discussion of investing game theory unlike anything you will get in business school." -- Dr. Peter Kolchinsky

Women in Biotech
Date:   Thurs, March 22, 2012
Description:

Correction: 5:00 PM – 6:30 PM

Fred S. Rosen Lecture Hall 100A 

(Modell Immunology Center, inside the Armenise building at 200 Longwood Avenue, Boston MA 02115)

 

Keynote Speaker:

Daphne Zohar, Founder and Managing Partner, Puretech Ventures

 

Panelists: 
Todd and Jill Milne (Founder, Ironwood & CEO, Catabasis)
Theresa Podrebarac (VP of Medical Research, Biogen Idec)

Jessica Flechtner (VP of Research, Genocea)


Moderator:

Mari Anne Snow, AWIS

 

Come and meet distinguished women leaders in the biotech industry and learn about their path to success, what they have learned, and how they have balanced their personal lives with their careers. Our stellar group of panelists includes a venture capitalist, biotech entrepreneurs, and executive leaders from biotech/pharma companies.

 

Men are invited and encouraged to attend!

 

A light dinner will be served.
 
This event is free for all Harvard students and Harvard/Harvard hospital affiliated postdoctoral fellows. For non-Harvard affiliated attendees, registration is $10 to be paid at the door. 

To register – send an email to thebiotechclub.rsvp@gmail.com with ‘Women in Biotech’ in the subject line by March 18th.

  

Speaker Bios

 

Daphne Zohar

Daphne Zohar is the founder and managing partner of PureTech Ventures, a Boston-based venture creation firm specializing in translating breakthrough research from top tier academic institutions into therapies that will impact human health. In 2010, Ms. Zohar was recognized by Fierce Biotech as one of the "Top 10 Women in Biotech”, by BioWorld as one of 28 leaders predicted to be the "movers and shakers" of the biotechnology industry over the next twenty years, and by the Boston Globe as one of the "Top 15 Innovators." A successful entrepreneur, Ms. Zohar created PureTech and assembled a leading team to help implement her vision for the firm. She sits on the Boards of Directors of PureTech Ventures, and several companies including Enlight Biosciences, Follica Inc., Libra Biosciences, Vedanta Bioscience, Mandara Sciences (where she is Founding CEO), Karuna Pharmaceuticals, Tal Medical, and Satori Pharmaceuticals. She also sits on the Technology Development Fund Advisory Board at Children's Hospital Boston and is an Editorial Advisor to Xconomy, a national technology news blog.

Todd Milne

Dr. Todd Milne, is the founder of Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. He has provided scientific management leadership since Ironwood’s founding in 1998, and has been vice president of biology since October 2001. Previously, Dr. Milne was a fellow at Whitehead Institute for Biomedical Research. Dr. Milne’s research has earned him numerous awards and acknowledgements including fellowships from Merck and the Damon Runyon-Walter Winchell Cancer Research Fund. He earned a B.S. in molecular biophysics and biochemistry from Yale University and holds a Ph.D. in microbiology and molecular genetics from Harvard Medical School.

Jill Milne

Dr. Jill Milne is the co-founder and CEO of Catabasis, a private, venture-backed biopharmaceutical company focused on creating new medicines for the treatment of inflammatory and metabolic diseases. She also serves on the company's board of directors. Prior to Catabasis, Dr. Milne worked at Discovery Biology and was part of the founding team at Sirtris Pharmaceuticals. Prior to Sirtris, Dr. Milne was the worldwide head of the Drug Pfinder Program at Pfizer Global Research and Development. As head of this global program, she was responsible for identifying and evaluating opportunities across all of Pfizer's therapeutic areas of interest. Additionally, Dr. Milne was the head of the Enzyme Target Group at the Pfizer Discovery Technology Center in Cambridge, Mass., where she directed a portfolio of projects from idea stage to proof-of-concept and integration into therapeutic areas across global Pfizer. Prior to joining Pfizer, she was an American Cancer Society postdoctoral fellow in the department of biological chemistry and molecular pharmacology at Harvard Medical School. Dr. Milne holds a Ph.D. from Harvard University and a B.A. in biological chemistry from Wellesley College.

 

 

Theresa Podrebarac

Dr. Theresa Podrebarac is the VP of Medical Research in Immunology at Biogen Idec. Prior to joining Biogen, she was the VP and global head of Rheumatology Clinical Development at EMD Serono, Inc., and the VP of clinical development at CombinatoRx and at Acceleron Pharma. Prior to joining Acceleron, Dr. Podrebarac served as a Medical Director of Clinical Development at Biogen Idec. She was responsible for Rituxan Phase 3 and Amevive Phase 2 clinical trials in arthritis. In addition, she introduced two new products into the clinic and played a critical role in the Tysabri BLA filing. Dr. Podrebarac is board certified in both Internal Medicine and Rheumatology and holds active appointments at Harvard Medical School and Brigham and Women’s Hospital. Dr. Podrebarac received her medical degree from the University of Western Ontario and completed her post-doctoral training and graduate studies in Immunology at Harvard University.

Jessica Flechtner

Dr. Jessica Flechtner is the VP of Research at Genocea Biosciences, a company focused on developing a new class of human vaccines based on a revolutionary platform for the rapid discovery of antigens that induce T cell immunity. Prior to joining Genocea, Dr. Flechtner was an Immunology Consultant at Biovest International, where she guided the development of assays to evaluate the success of the company’s autologous Follicular (Non-Hodgkin's) Lymphoma vaccine in patients. As a researcher at Mojave Therapeutics, Inc. and Antigenics Inc., which acquired Mojave's intellectual property, Dr. Flechtner developed protein and peptide-based vaccines and immunotherapies for cancer, infectious disease, autoimmunity and allergy. She is an inventor on nine pending or issued patents and has multiple peer-reviewed scientific publications. Dr. Flechtner performed her post-doctoral work in the laboratory of Dr. Harvey Cantor at the Dana Farber Cancer Institute and Harvard Medical School and holds a Ph.D. in Cellular Immunology and B.S. in Animal Science from Cornell University. She is a member of the American Association of Immunologists and the American Association for Cancer Research.

Mari Anne Snow

Mari Anne Snow is an organizational development and change management professional with over 20 years experience utilizing technology to support non-disruptive change.  She is CEO of SophiaThink, a management consulting firm that helps clients develop high performing virtual teams using new technologies. Before SophiaThink, Mari Anne held senior positions as a business technologist and organizational development professional at the State Street Corporation.  Mari Anne is an Adjunct Professor at Bentley University; on the Board of Directors of WEST, a non-profit dedicated to the advancement of women in science and technology; and a contributor to Data Guidance, an international privacy publication.  She is also the resident social media guru for Patricia Raskin’s radio show – Positive Business on Rhode Island’s WPRV AM790.

 

Genentech Day
Date:   Wed, March 21, 2012
Description:

4:00 pm -  5:30 pm (Pizza will be provided!)

Bray Room, NRB

 

Agenda: 

4:00 - 5:00 pm - Corporate presentation and Genentech employee speakers           

5:00 - 5:30 pm – Networking session.

 

Do you want to know why Genentech has been voted one of the Best Places to Work by The Scientist as well as Top Employer by Science Magazine?

 

Do you want to learn more about both research-related and business-related internships and job opportunities at Genentech?

 

Do you want to learn how to shape your graduate career for a future in one of the biotech industry’s leading companies?

 

Then come to GENENTECH DAY to learn about the company & network with recruiters as well as industry leaders!

 

Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 35 years, using human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, Genentech is among the world's leading biotech companies, with multiple products on the market and a promising development pipeline. Genentech, one of Forbes Top 100 Best Companies to work in for the 14th year, is coming to Harvard. Genentech recruiters and employees will discuss their unique company culture, opportunities for upcoming internships as well as how to use your degree in the industry. Join HBC for this exciting event!

 

Registration: Space is limited to current first and second year Harvard graduate students. To RSVP, send an email to rsvp@thebiotechclub.org with ‘Genentech’ in the subject line by March 16th.

   
Patent Law info-course
Date:   Thursdays, Mar 1, 8, 15, 22
Description:

Time: 4:30-6:30pm

Venue: TMEC 109

 

For those who hope that the end of their graduate studies also means the end of the latex gloves’ itch and the sore thumb resulting from endless pipetting, this is for you:

 

In collaboration with Clark & Elbing, LLP, a Boston-based intellectual property law firm, The GSAS Harvard Biotech Club & DMS Law PATH is organizing a 4-week Patent Law info-course for Harvard affiliated students and postdocs.

 

Please register here https://docs.google.com/spreadsheet/viewform?formkey=dHExcXRLNGJVYnVOd0prdHRKVWpidWc6MQ before Wed, Feb 22 to reserve your spot. You will be notified on whether you have been accepted to attend the course by Mon, Feb 27, 2012.

 

Brief Syllabus:

Class 1: Introduction to the patent system and patents in general

Class 2: Discussion on two court cases

Class 3: Drafting claims of a patent application

Class 4: Conducting a Freedom to Operate Search and Validity analysis

 

 

Charting a Complex World: How TechAtlas and RA Capital Identify Investment Opportunities

(TechAtlas is now recruiting analysts)

Date:    Thursday Dec 8th, 2011
Description:

Time:   5:30 – 7:30 pm

Venue: Goldenson Building Rm 122, Harvard Medical School, 220 Longwood Ave, Boston (next to Courtyard Cafe; HMS campus Map)

 

Speaker: Peter Kolchinsky, PhD.  Managing Director, TechAtlas and RA Capital Management, Graduate of DMS/Virology (Sodroski Lab), co-founder of Harvard Biotech Club

 

Food will be provided.

 

TechAtlas is a healthcare strategy and competitive analysis research group recently spun out of RA Capital, a healthcare-focused fund that has successfully invested in public and private drug, diagnostic, and device companies over the last 10 years. TechAtlas’ purpose will be to conduct the kind of research and competitive analysis of different companies/products that RA Capital has been doing since 2002 but now for the benefit of biotech and pharma companies.

 

Come to this event to meet our team and learn about how we consume massive amounts of data about thousands of technologies by speaking with physicians and company management teams as well as attending scientific, medical, and investor conferences to create “atlases” that highlight the products most likely to address important unmet needs.

 

Ultimately, everyone is an investor – funds invest capital, companies invest their people and money, and people invest their own time and reputations.  Even academic researchers need to think in terms of where they want to invest their time and creativity.

 

TechAtlas maps out competitive landscapes - for example, there are dozens of Hepatitis C (HCV) drugs in development, but only a few are special, so if you are thinking of investing in HCV or considering getting a job at an HCV company, you’ll first want to see which companies are positioned well to win (hint: high-barrier to viral resistance, pan-genotypic activity, oral bioavailability, potent anti-viral activity = nucleotide polymerase inhibitors).  We’ll show you our map of the HCV landscape at the event so you see what we mean… as well as maps of oncology, antibiotics, Alzheimer’s, pain, nephrology, etc.

 

If you find this interesting, bring a resume and apply for one of the open analyst positions at TechAtlas (it’s like getting an MBA in Biotechnology, without the debt). 

 

To learn more: www.techatlasgroup.com and www.racap.com

 

RSVP: If you would like to attend this event, please send an email to RSVP@thebiotechclub.org with "TechAtlas" in the subject line.

 

   
Intellectual Property and Patent Law Panel
Date:    Wednesday Dec 7th, 2011
Description:

Time:   4:30 – 6:00 pm

Venue: Bray Room, New Research Building (NRB)

 

Tired of pipetting everyday? Looking for opportunities outside academia? Come meet with people that were once on the same page with you!

Harvard Biotech Club is proud to present the patent law discussion panel featuring

Michael J. Belliveau, Partner at Clark & Elbing, LLP

Jo Parente, Legal Hiring Manager at Wolf, Greenfield & Sacks, P.C.

Maryanne Trevisan, Shareholder at Wolf, Greenfield & Sacks, P.C.

Vivien Tannoch-Magin, Associate at Hamilton, Brook, Smith & Reynolds, P.C.

Deniel Lev, Associate at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 

 

*Amy Sanford, assistant director of Harvard University Office of Career Services will moderate the discussion 

 

Pizza will be served! No registration required.

- Discover career opportunities at the intersection of science, technology and business strategy

- Hear from people that have successful made the career transition outside the academia 

- Unique chance to learn about patent law firms in Great Boston area and get recruiting tips

Harvard Biotech Career Fair 2011
Date: Thursday, Sep 29, 2011
Description:

Time:   1.00 - 5.00PM

Venue: 3rd Floor Rotunda, New Research Building, Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map)

 

See our Career Fair website

 

Making the Most of the Harvard Biotechnology Club's Career Fair: Resumes and Networking
Date: Wednesday, Sep 14, 2011
Description:

Time:   3 - 4.30PM

Venue:

Warren Alpert Building, Room 563

 

*Note: Due to space limitations, the workshops will be open only to Harvard-affiliated members.
 

To help you prepare for the Harvard Biotech Career Fair, Amy Sanford of the Office of Career Services for Harvard's Faculty of Arts and Sciences, will present this two-part workshop. In part one, we will discuss the conundrum scientists face when applying for jobs outside academia: should you submit a CV, a resume, or something in between? Learn how to best organize and present your background and experience for different types of PhD-level non-academic positions. In part two of the workshop, you will learn how to effectively introduce yourself to potential employers and make the most of your time at the HBC Career Fair.
 

RSVP: If you would like to attend this event, please send an email to hbc.careerfair@gmail.com with "workshop" in the subject line.

Massachusetts Life Sciences Innovation Day 2011
Date:

June 2, 2011 

Description:

Time:   

8 a.m. - 7 p.m  

Venue: Harvard Club of Boston, 374 Commonwealth Avenue, Boston

 

Building Biotech Backward  

 

 

You're a great scientist, you have a great idea, but what comes next? This is the conference where academia and business collide to create a high-energy, hands-on event bringing together scientific leaders and business experts to mingle with innovators, post-docs, professors, entrepreneurs, innovators, and venture capitalists.  Hear from entrepreneurs and scientists who are experts at the process of transforming ideas into products.

     

Featured Keynotes:

  • Nobel Laureate Sir Richard Roberts, SCO, New England Biolabs - opening keynote
  • Dr. Todd Zion, President and CEO, SmartCells Inc.  - lunch keynote
  • Benjamin Conway, Founder and Managing Director, Johnston Blakely & Company - State of the Union address    

We have more than 50 speakers who will provide tons of opportunities for you to interact close-up with Founders, CEOs, Investors and Experts to get your questions answered.  Our Speakers include: 
Founders and CEOs: Stan Lapidus, Founder of  Cytyc, Helicos and SynapDx; Richard Melanson of HiLo Microscopy; Andrew Golden of Daktari; Bill Edelman of MindChild; Kees Been of EnVivo;  Ali Munawar of Novira; Ajit Bharti of Predictus
Venture Capitalists: Aaron Sandoski of Norwich Ventures; Andrew Jay of Siemens Venture Capital; Kevin Bitterman from Polaris
Experts: Virginia Carnahan of Vertex; Eric Olsen from Vertex; Jay Knowles of Novartis; Johannes Fruehauf of Vithera Labs; Scott Brown from Novartis 

 

For a full list see the Agenda  on the website  

  

Our Theme is "Building Biotech Backward"

: What are the secrets to building a successful startup? We believe the best way is to "build your biotech backwards" and consider how all the issues that you will face in your successful company 5-10 years from now influence your ideas today. We will debate some of the big issues on "building biotech backwards" while brainstorming with your ideas to increase the chance of your startup becoming the next success story.
 
 
Actively participate in 9 Open Discussions
 that include Careers outside of Academia; Intellectual Property for Start-ups; Inside a VC firm; Hot Diseases; Partnering with Pharma/Bioech; Early money: Angels & Grants; How to start a Biotech company; How to start a Medtech
company; and How to start a Diagnostics company.    

Vote for

 the best posters at the Big Undiscovered Idea Poster Competition.  

 

Don't miss the opportunity to network

 at the Reception with more than 35 CEOs and Senior Executives of leading MA Life Sciences companies that include Ab-Pro, Aileron Therapeutics, Inc., Anchor Therapeutics, Anterion Therapeutics, Apredica, Avila Therapeutics, Inc, Bach Pharma, BIND Biosciences, Inc, Cerulean Pharma Inc., Concert Pharmaceuticals, Inc., Corum Medical, CreaGen Biosciences, Inc., Dicerna, EnVivo Pharmaceuticals, Inc., Enzymatics, Excelimmune, Inc., Faber, Daeufer & Rosenberg, Flagship Ventures, Genzyme Ventures, InVivo Therapeutics Corporation, Lipimetix, Mind Child, MVM Life Science Partners, NeuroPhage Pharmaceuticals, Neuroptix, NKT Therapeutics, Northshore Innovation labs, Organogenesis, Inc., Seaside Therapeutics, Inc., Selventa, Smart Cells, Tetragenetics, and Tomophase. 

Join us
 
for the flagship event of life sciences in Massachusetts, jointly and actively put together by all the major organizations that are involved in starting and supporting the life sciences startup ecosystem in the Commonwealth.

 

CONFERENCE FEES

On-line registration will be open until June 1st at 10am.

  • $190 Academics/staff at MATTO member institutions and Members of MassBio
  • $235 Non-members
  • $60 Students and post-docs (ID's will be required at the event)
  • $550  Innovators' Marketplace Exhibitor (includes two attendees). Service providers will only be allocated space in the exhibit hall if they sponsor the conference - for a listing of sponsorship opportunities please visit our Sponsorship page.
  • $75 Reception only  - includes poster competition, CEO Reception and Innovators' Marketplace (5-7 pm only)

 

 

ABOUT MALSI

Massachusetts Life Sciences Innovation Day has been developed by the Massachusetts Life Sciences Start-up Initiative (MALSI). MALSI is a platform organization that brings together all major public and private entities in the State that are committed to building the next generation of Massachusetts companies. MALSI's mission is to ensure that Massachusetts maintains its lead as the #1 region in the world to start, nurture and grow life sciences companies.

 

MALSI partners include: Massachusetts Technology Transfer Center,

Mass Biotech Council, TiE Boston, and several major universities and research hospitals.

 

 

TiECON East 2011


Description: TiECON East 2011 is a Premier Entrepreneurial conference that offers convergence of Technology, Life Sciences and Clean Tech under one roof. The theme is Innovate Now: Launch ~ Leverage ~ Lead and will be held June 2-3rd in Waltham, MA. This is the place to interact with thought leaders, successful entrepreneurs, luminaries and VC’s. Register now to get TiE member discount. Visit: www.tieconeast.org

 

Key Highlights:

·         Captivating entrepreneurial stories from industry pioneers.

·         ‘Thursday Night Keynote Panel’ of entrepreneurs from India.

·         Entrepreneur Forum (E-Forum) to seek advice on business ideas from VCs and  industry experts.

·         Panel Sessions on Technology, Life Sciences and Clean Tech

·         BootCamp entrepreneurial workshops

·         Targeted networking sessions at ValueConnect

·         Banquet Speaker & Dinner 

Time:    June 2 (2:00 pm-9:30 pm), June 3 (8:00 am - 9:30 pm)
Price:   Get discounted entrance fee
 - Use promo code: TiE-AP
Place:
  The Westin Hotel, Waltham MA

Sponsoring Organization: TiE-Boston

 

Registration: 

https://s08.123signup.com/servlet/SignUpMember?P=15219721911422438300&PG=1521972182300       

Healthcare & Biotech Consulting Panel
Date: Tuesday May 17th, 2011
Description:

Time:   5:30 - 7:30 PM

Venue: Cannon Room, Bldg C, Harvard Medical School

 

If you are curious about healthcare/Biotech consulting, come join us for a panel discussion about this exciting career! Take this opportunity to talk to consulting professionals from 7 leading firms during the networking


Companies participating:
Clarion Healthcare
Clearview
Leerink Swann Consulting
Munevar & Associates
Scientia Advisors
The Kerdan Group
Tunnell Consulting:

GCC Business Seminar with Prof. Vicki Sato
Date: Wednesday, May 4, 2011
Description:

Time:   6 - 7PM

Venue:

Northwest Building Room B103 (note location change!) (map)

 

The HGCC Business Knowledge Development team is happy to announce the fourth seminar in the new HGCC Business Seminar Series!   Professor Vicki Sato, a joint professor in the Harvard Business School and the Molecular and Cell Biology Department will be answering our questions in an interactive discussion about Science and Business in Science-Based Companies. 
Company Presentation on Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P
Date: Thursday, March 30,  2011
Description:

Time:   5.30 - 7.30PM

Venue: TMEC 250, Longwood Medical Area, Harvard Medical School, 260 Longwood Ave, Boston

 

Come meet with company representatives and learn about the firm and a career path in Intellectual Property/Patent Law.  Harvard PhDs and postdoctoral fellows from biological sciences, engineering, chemistry are all invited to this event.  Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. is one of the largest law firms in the world focusing solely on intellectual property law.  The firm practices all aspects of U.S. and international patent, trademark, copyright, and trade secret law, including transactions, counseling, prosecution, licensing, litigation, and portfolio management. 
An Evening with Third Rock Ventures
Date:  Tuesday, March 8, 2011
Description:

Time:   5.30 - 7.30PM

Venue: Goldenson Building Rm 122, Harvard Medical School, 220 Longwood Ave, Boston

 

The Harvard Biotech Club invites interested students and post-docs to an informative presentation led by one of the Founders of Third Rock Ventures (TRV), a venture capital firm located in Boston and San Francisco. 

 

TRV is focused on launching exceptional life science companies, working in areas of disruptive science to make a difference in the lives of patients. TRV team members will be on-hand to talk about how TRV’s dedicated focus on early stage life science investments, leads to company formation, and share their personal stories of how their individual career path has led them to the venture industry.


 

Harvard Biotech Club Annual Career Fair 2010
Date:   Wednesday November   3, 2010
Description:

Time:   1.00 - 5.00PM

Venue: 3rd Floor Rotunda, New Research Building, Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map)

 

See our Career Fair website
 

Making the Most of the Harvard Biotechnology Club's Career Fair: Resumes and Networking
Date:   Tuesday October 19, 2010
Description:

Time:   2.30-4.00PM

Venue: Warren Alpert Building, Room 341

 

*Note: Due to space limitations, the workshops will be open only to Harvard-affiliated members.

Excited about the upcoming Harvard Biotechnology Club Career Fair?

To help you prepare for the career fair, Laura Malisheski of the Office of Career Services for Harvard's Faculty of Arts and Sciences, will present this two-part workshop. In part one, we will discuss the conundrum scientists face... when applying for jobs outside academia, should you submit a CV, a resume, or something in between? Learn how to best organize and present your background and experience for different types of PhD-level nonacademic positions. In part two of the workshop, you will learn how to effectively introduce yourself to potential employers and make the most of your time at the HBC Career Fair.

RSVP: If you would like to attend this event, please send an email to RSVP@thebiotechclub.org with "workshop" in the subject line.

Presented to you by the GSAS Harvard Biotech Club in collaboration with Harvard FAS Office of Career Services

 

Decision Resources – Consulting Information Session
Date:   Tuesday September 21, 2010
Description:

Time:   5.30-7.30PM

Venue: Cannon Room, Building C, 240 Longwood Ave, Harvard Medical School

 

Interested in healthcare consulting? Decision Resources is hiring for the summer and full-time!
Stop by the information session to learn more. Food will be served.

DR Consulting, the strategic consulting arm of Decision Resources, partners with senior executives in leading pharmaceutical and biotech firms in the US, Europe and Asia to evaluate their portfolios, assess product and market opportunities, and maximize the value of their products. DR Consulting leverages the expertise of DR’s highly-credentialed therapeutic experts, its published and unpublished research, its network of key opinion leaders and high prescribing physicians, and its considerable library of key industry sources to deliver strategic consulting services to DR’s clients. This unique combination of content with consulting expertise allows DR to provide unequalled value to our consulting clients.

 

Healthcare Consulting Panel Discussion and Networking Session
Date:   Wednesday August 18, 2010
Description: Open to Harvard students & postdocs & affiliates of Harvard teaching hospitals
 

Harvard Biotechnology Club, Biomedical Graduate Student Organization and the Harvard Graduate Consulting Club invite you to a Healthcare Consulting Panel Discussion and Networking Session featuring:

Clarion Healthcare Consulting
Clearview Healthcare Partners
Decision Resources
Health Advances
LEK Consulting

- Discover career opportunities at the intersection of science, technology, healthcare and business strategy
- Unique chance to learn about exclusively healthcare-focused consulting firms and get recruiting tips
- Hear from consultants about how healthcare consulting is distinct from other types of consulting

Time: August 18th, Wed

5:30 – 7:00pm - panel discussion with Q&A

7:00 - 8:00pm - networking session
Location: Cannon Room, C building, Harvard Medical School Longwood Campus

Registration is not required but highly appreciated: rsvp@thebiotechclub.org
Dinner will be provided.

This event is sponsored by Harvard Biotechnology Club, Biomedical Graduate Student Organization and Harvard Graduate Consulting Club

 

Panelists

 

Steven Chao is a founding partner at ClearView Healthcare Partners where he has led therapeutic area growth strategy, clinical development strategy, and product launch strategy engagements, as well as due diligence and asset search projects, spanning multiple therapeutic areas.  He joins ClearView from Leerink Swann Strategic Advisors, where he was a Vice President.  He joined Leerink Swann in 2004 from McKinsey and Company, where he led strategic engagements in the pharmaceutical, biotechnology, payer, and provider industries.  He received his M.D. and his Ph.D. from Harvard Medical School.  He has published over 20 articles and led neuroscience research in the laboratories of Dr. Lawrence Benowitz and Dr. Jonathan Seidman.  He graduated summa cum laude with his B.A. in Biochemistry from Harvard College.

 

Mike DeRidder  is a manager at L.E.K. Consulting, LLC focused in the life sciences practice. He joined the firm in the summer of 2005 and is based in the Boston office. Mike has recently completed projects assessing the landscape of medical technology and devices as well as venture capital investment trends in this area, formulating and assisting with the execution of an M&A strategy for a major pharmaceutical company, and assessing the value of a royalty stream associated with a blockbuster pain therapy. In addition, he has helped to develop a strategic plan for gaining reimbursement approval for a product-specific diagnostic test in schizophrenia and conducted a detailed assessment of potential acquisition candidates in gastroenterology for a large biotechnology company. Before joining L.E.K., Mike received his Ph.D. in Bioengineering at the University of Pennsylvania. In 1999, Mike received a Bachelor of Science in Engineering, majoring in Biomedical Engineering, from Tulane University.

 

Daniel J. Hawkins is a founding member of Clarion Healthcare Consulting. Mr. Hawkins has over 20 years of experience in healthcare, having worked with companies ranging from global pharmaceutical companies to development stage biotech and device companies, as well as venture capital/private equity firms that invest in the area. He has worked in functional areas from product development through sales, on issues from product acceleration to board-level M&A advice, and in therapeutic areas ranging from oncology to orthopedics. In addition, Mr. Hawkins has extensive depth in managed care and the payer side having worked with health plans such as WellPoint and New York Life, provider groups, such as Fallon Clinic, and retail pharmacies, such as Wal*Mart. Mr. Hawkins also serves as a Director of M|C Communications, the leading medical education company in the US.Prior to founding Clarion, Mr. Hawkins was President of Hawkins Associates, a consulting firm providing advisory services to emerging and mid-cap healthcare companies as well as financial investors. Mr. Hawkins was CEO of a development stage medical device company. He spent his first 10 years at the consulting firm of Corporate Decisions, Inc., where he was partner, co-head of the healthcare practice and elected one of three members of the Management Committee. Mr. Hawkins has an MBA from the Yale School of Management, and an AB in Economics from Princeton University.

 

Lily Kim is a Consultant at Decision Resources with specific expertise in evaluating emerging therapies and opportunity assessment. Dr. Kim received her Ph.D. in Biomedical Engineering from the Harvard-MIT Division of Health Sciences and Technology at the Massachusetts Institute of Technology and was awarded a Hertz Foundation Fellowship for her graduate work. While at MIT, Lily researched microfluidic control of stem cell environments. Her work has been presented at several conferences, including the International Society for Stem Cell Research, and published in prominent engineering journals. As part of an MIT Sloan School team, she helped assess the commercial opportunity surrounding microfluidic platforms for testing liver toxicity and presented this work at the IdeaStream entrepreneurship conference. She graduated with an S.B. in Electrical Engineering at the Massachusetts Institute of Technology.

 

Kristin Ciriello Pothier  is a vice president leading the Diagnostics and Discovery Tools Practice at Health Advances, a global practice which meshes her consulting and scientific experience to provide results-oriented commercialization strategies for her clients in the biotech and clinical diagnostics sectors, including focus on launch strategy, pricing, and R&D prioritization for novel diagnostics and biotech platforms for the research laboratory, personalized medicine, point-of-care, and mainstream clinical diagnostics. Her clients range from small diagnostics and tools start-ups to the largest public companies and non-profit institutions in the industry. Kristin is a frequent speaker, workshop leader and writer in the diagnostics and life sciences industries, covering topics such as the future of point-of-care platforms, the commercialization of companion diagnostics, and innovations in personalized medicine. Kristin joined Health Advances in 2002 with extensive experience as a research scientist in the diagnostics and drug discovery industries. Prior to joining Health Advances, Kristin focused on diagnostics technology development at Genzyme and genomics research at Genome Therapeutics. She has an undergraduate degree in Biochemistry from Smith College and a Masters degree in Epidemiology, Health Management, and Maternal and Child Health from the Harvard School of Public Health

 

Globalization in Life Sciences Forum
Date: Tuesday April 27, 2010
Description: Globalization in Life Sciences, April 27

Come hear about the global revolution in the life sciences industry from eminent panelists with vast international experience spanning Europe, China, India, the Middle East and more. This event will illustrate how governmental policy, culture, and education can influence a country's research and business innovations.

Date : April 27th, 2010 (this Tuesday)

Time :
5:15pm-6:30 pm Panel 1 : The State of Global R&D in Life Sciences
6:45pm-8:00 pm Panel 2 : Global Life Sciences Start-up Trends

Location : Cannon Room, HMS 

~Refreshments will be served at the event. ~

Panel #1: The State of Global R&D in Life Sciences

This panel will focus on the nature of life sciences R&D in Asia and Europe and how they compare to practices in the US as well as career opportunities outside the US for scientists. The panel will explore the R&D strengths of different countries and the types of global research collaborations that are being set up by companies. Additionally, the panel will also examine how governmental initiatives and policies are fostering the development of R&D practices around the world.

Speakers :
Sandra Glucksmann, SVP Research at Cerulean
Eli de los Pinos, CEO, Aura Biosciences
Shiladitya Sengupta, Professor of Health Science & Technology, MIT
John Thomson, VP Research, Vertex Pharmaceuticals
Xiaolin Zhang, Head of R&D China, Astra Zeneca

Moderator: Mark Namchuk, Head of Research, Vertex Pharmaceuticals

*

Panel #2: Global Life Sciences Start-up Trends

 

This panel will provide an investment outlook and operational analysis on the current and future start-up environment in China, India, Europe, and the Middle East. Specifically, the current trends and future potential for the emergence of service providers and fully functioning life sciences companies in different countries around the world.

Speakers:
Pravin Chaturvedi: President/CSO of Napo Pharmaceuticals & Founder/CEO of IndUS Pharmaceuticals
Florent Gros: Managing Director of Novartis Venture Fund in Basel, Switzerland
Jinbo Lee: President at Sage Partner International; Senior Advisor at Shanghai Medicilon Inc.
Anupendra Sharma: Partner, Siemens Venture Capital

Moderator : Wei Zhang, Founder and President,
Harvard Square Consulting
 

GSAS Harvard Biotechnology Club Spotlight event: Innovations, Entrepreneurship & Development
Date: Thursday March 4, 2010
Description: GSAS Harvard Biotechnology Club Spotlight event: Innovations, Entrepreneurship & Development

March 4, 2010 515pm -715pm

Cannon Room, Bldg C, Harvard Medical School

515 - 550 pm: Talk 1: Prof Iqbal Z. Quadir

550 - 625 pm: Talk 2: Dr. Una Ryan

630-645 pm: Q/A Session/panel discussion

645-715 pm: Networking reception with speakers and social enterprise companies [Seeding Labs, SolSolution, etc]

Speakers:

UNA RYAN, OBE, PhD, DSc CEO, Diagnostics For All & Research Professor of Medicine at Boston University School of Medicine

Dr. Ryan is the current CEO of Diagnostics For All and was formerly the President and CEO of AVANT Immunotherapeutics, Inc., a publicly traded biopharmaceutical company developing vaccines. Dr. Ryan is also Research Professor of Medicine at Boston University School of Medicine and serves on its Board of Visitors. She serves on a number of boards including Waltham Technologies Inc., AMRI Global, IQuum, the Business Advisory Board of BIO Ventures for Global Health, the Scientific Advisory Board of Genocea, Inc. Dr. Ryan holds a Ph.D. in Cellular and Molecular Biology from Cambridge University and an Honorary Doctor of Science Degree from Bristol University in 2009. She was a Howard Hughes Investigator, NIH MERIT Awardee and an Established Investigator of the American Heart Association.

Diagnostics for All is a Cambridge based non-profit enterprise fusing biotechnology and microfluidics, dedicated to creating low-cost, easy-to-use, point-of-care diagnostics designed specifically for the 60% of the developing world that lives beyond the reach of urban hospitals and medical infrastructures. Professor George Whitesides and his team at Harvard University have pioneered the technology underlying the devices.

IQBAL Z. QUADIR, Director and Founder, MIT Legatum Center for Development & Entrepreneurship & Professor of Practice, MIT Professor

Iqbal Z. Quadir is the founder and director of the Legatum Center for Development and Entrepreneurship at the Massachusetts Institute of Technology (MIT) and founder of Grameenphone Limited in Bangladesh.

From 2001-2004, Quadir taught at the John F. Kennedy School of Government at Harvard University, focusing on the democratizing effects of technologies in developing countries. In 2005, he moved to MIT where he co-founded the journal Innovations (MIT Press) and founded the Legatum Center for Development and Entrepreneurship. Professor Quadir holds both an MBA and an MA from the Wharton School, University of Pennsylvania, and a BS with honors from Swarthmore College. The

Legatum Center for Development and Entrepreneurship was founded on the belief that economic progress and good governance in low-income countries emerge from entrepreneurship and innovations that empower ordinary citizens. The Center administers programs and convenes events that promote and shape discourse on bottom-up development.

Moderated by: CROCKER SNOW, Jr. Director, Edward R. Murrow Center for Public Diplomacy at Tufts University Fletcher School of Law and Diplomacy

President, The Money Matters Institute (1996-present); President, World Times, Inc (1979-2001); Editor in Chief, The WorldPaper (Boston) (1979-2001); National and Foreign Editor, The Boston Globe (1976-1978); Assistant to the Publisher, The Boston Globe (1976-1978); Chief Foreign Correspondant for East Asia, The Boston Globe (1972-1974); Assistant Managing Editor, The Boston Globe (1970-1971). ~

Presentation will be followed by a networking reception. Food and drinks will be served~

Please RSVP at rsvp@thebiotechclub.org (Appreciated but not required)

Questions?: Contact Shaila Rahman, shaila@thebiotechclub.org To learn more about the Harvard Biotechnology Club, visit our Website: www.thebiotechclub.org
MassCONNECT: promoting life-sciences entrepreneurship in Massachusetts
Date: Tuesday January 26, 2010
Description: MassCONNECT - leveraging the life sciences ecosystem to catalyze innovation.

Are you interested in starting a life sciences based company, either as a founder or entrepreneur? MassCONNECT can assist you in getting your ideas and technology crystallized into a business opportunity for presentation to the investment community. We are here to help you think about and think through your business opportunity, and most importantly, connect you to the enablers of the biopharmaceutical industry.

Why you should use MassCONNECT:

v showcase your technology to industry experts comprising biopharmaceutical executives, venture capitalists, and angels;

v connect with individuals and teams of mentors who will provide practical advice on how to increase the value of your opportunity;

v receive coaching to prepare for investment pitches and develop concise business plans;

v connect to resources to improve your idea;

v connect you to avenues for financing your technology;

v network into business professionals to develop your management team.

Presented by Imran Nasrullah, Chief Business Officer of Massachusetts Biotech Council.
Genentech Day
Date: Monday November 9, 2009
Description: The GSAS Harvard Biotech Club presents

GENENTECH DAY

Date/Time: November 9, 2009; 11am-2pm
Location: NRB, Rotunda

Tentative agenda: 11am-12:30pm: Genentech presentation/panel. 12:30pm- : Networking lunch

Please RSVP at rsvp@thebiotechclub.org. Space is limited to current Harvard & Harvard hospital-affiliates.

Do you want to know why Genentech has been voted one of the Best Places to Work by The Scientist as well as Top Employer by Science Magazine?

Do you want to learn more about both research-related and business-related job opportunities at Genentech?

Are you curious about how the Roche presence will influence research and culture at Genentech?

Are you looking for a JOB at this leading biotech firm located at sunny California??

Then come to GENENTECH DAY to learn about the company & network with recruiters as well as industry leaders!

As part of Sponsorship event, Genentech leaders in research, commercialization, manufacturing and product development will be coming to the HMS campus for presentation & recruitment. They are extremely excited to meet the Harvard community - and hoping to recruit great talents from here!!

Confirmed speakers include:

William Annett, MBA: Director of Business Information Management (Commercial Management)

 

William Annett received his MBA from the Harvard Business School. His career has consisted primarily of senior roles in rapid growth situations in the healthcare industry. For the past 6 years Mr. Annett has worked in various positions at Genentech in San Francisco, CA. As Director of Business Information Management he is responsible for Commercial business intelligence, reporting, and liaison with the internal IT organization. At the current time he is very involved in the integration of Genentech and Roche¡¦s Commercial IT solutions and business processes. This role has also included leading the Commercial Blueprint, one of the largest change initiatives in Genentech¡¦s history. This $150 million effort replaced Sales & Marketing¡¦s outdated legacy IT systems and business processes with a fully integrated platform featuring more robust capabilities, greater simplicity and cost efficiency. Prior to this role Mr. Annett was Director R&D Finance at Genentech, and led a group of 16 responsible for a budget in excess of $1 billion supporting the R&D pipeline. Mr. Annett has had extensive experience in entrepreneurial finance and management. He has developed 4 early stage companies, including founding a company, taking it public on NASDAQ and running it for 6 years as CEO. Mr. Annett also played a key role in the turnarounds of four other organizations, three times as Chief Executive. He has served on the Board of Directors of a number of early stage companies.

Deborah Baly, Ph.D: Senior Director, Quality, PT (Manufacturing)


Deborah received her Ph.D. in Nutritional Biochemistry from University of California, Davis and began her career in academia at Rutgers University. Deborah transitioned to industry and held director level positions at Bayer Biotechnology in Berkeley, CA and Exelixis, Inc. in South San Francisco, overseeing cell based validation of novel therapeutic targets for both antibody and small molecule therapeutics. Deborah has over 15 years of biotechnology experience, originally joining Genentech in 1991 as a scientist in the Medicinal Analytical Chemistry (MAC) group working on ELISA and cell based assays to support clinical product development. During her previous tenure at Genentech, Deborah served as assay subteam leader on several project teams, including both Herceptin and Avastin core teams. Since 2004 Deborah has held positions of increasing responsibility in the Quality Bioanalytical Development group, including responsibility for leadership of the Clinical Quality Product Stewards, execution of the quality system activities related to clinical products, such as lot release, product investigations, viral and process validation, devices, and appropriate documentation of processes and specifications. Deborah currently serves as Senior Director Corporate Product Quality Support in Genentech¡¦s Pharma Tech division.

 


Chudi Ndubaku, Ph.D: Medicinal Chemist, Research and Early Development (Research)


Chudi Ndubaku was born in Enugu, Nigeria. After moving to the United States, he completed his undergraduate studies at the University of California, Berkeley where he received his BS in Chemistry in 2001. He then went on to pursue a Ph.D. in Organic Chemistry at the Massachusetts Institute of Technology in research related to natural product total synthesis. After the completion of his work there in 2006, he joined the Medicinal Chemistry department at Genentech. His research at Genentech has focused on combating different mechanisms that drive cancer proliferation and evasion of apoptosis. He very much enjoys living in the Bay Area and his hobbies include biking, golfing and basketball.

Christine Ryan, MS: Medical Liaison, Medical Affairs (Clinical Affairs)


Christine Ryan completed her undergraduate studies at the State University of New York and her Masters of Science in Nursing from Simmons College in Boston. Christine worked as a Nurse Practitioner in oncology for over ten years. She initially entered the biotech industry as a Patient Care Consultant for Schering Plough and joined Genentech in 2003. Christine¡¦s roles at Genentech have included Oncology Coordinator, a role focused on nursing education related to Genentech products. In that role she was involved in the launch of Tarceva and Avastin. She currently works as a Medical Science Liaison facilitating and managing both sponsored and supported trials as a field based member of the Clinical Science Organization.

Will Smiley: Associate Director, College & Staffing Programs (Recruiting)


Will Smiley is the Associate Director for College and Staffing Programs at Genentech. He is responsible for developing and driving Genentech¡¦s university recruitment strategy that sources talent for Genentech¡¦s intern and co-op programs. Prior to Genentech, Will worked in international development on economic, education and democracy development programs around the globe including five years in Ukraine where he managed Freedom Support Act programs for the US State Department. Will served as a training specialist at USAID and worked with USAID contractors on business development in Washington, DC for four years. Will has a MSc in Organizational Management from the School for International Training in Brattleboro, VT and a BA in Psychology from Humboldt State University in Arcata, CA.

About Genentech: Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline and a long term plan for growth. Genentech's mission is to be the leading biotechnology company, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Genentech is committed to high standards of integrity in contributing to the best interests of patients, the medical profession, employees and communities, and to seeking significant returns to the stockholders, based on the continual pursuit of scientific and operational excellence. Genentech was founded by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. After a fateful meeting in 1976, the two decided to start the first biotechnology company, Genentech.

HBC Career Fair 2009
Date: Wednesday October 7, 2009
Description: The GSAS Harvard Biotechnology Club proudly presents Career Fair 2009, at the Harvard Medical School.

Date: Wednesday, Oct 7th, 2009

Time: 1.00-5.00PM

Venue: New Research Building, Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map)

Attending this year's fair are a number of firms representing the sectors of Biotech, Consulting, Patent law and Pharmaceutical.

Visit http://www.thebiotechclub.org/careerfair2009/ for list of companies attending.

In addition there will be a series of 20 min Presentations by recruiting companies over the afternoon, and a Panel Discussion by various industry leaders on growth opportunities in the biotech industry today, employers' perspectives on what makes an attractive candidate, and suggestions for the transition from academia to industry.

*Job applicants/attendees: Please bring resumes/cv's and questions for companies!

*For Harvard-affiliated members attending the career fair: please also bring your Harvard ID.

*For non-Harvard-affiliated members attending the career fair: we will charge $20 for students and $40 for non-students at the door.

 

Making the Most of the HBC Club's Career Fair: Resumes and Networking
Date: Wednesday September 30, 2009
Description: Making the Most of the HBC Club's Career Fair: Resumes and Networking

Time: Wednesday, September 30, 2009. 3-4:30 PM

Location: Warren Alpert Building, Room 341

*Note: Due to space limitations, the workshops will be given priority to Harvard-affiliated members.

Excited about the upcoming Harvard Biotechnology Club Career Fair?

To help you prepare for the career fair, Laura Malisheski of the Office of Career Services for Harvard's Faculty of Arts and Sciences, will present this two-part workshop. In part one, we will discuss the conundrum scientists face... when applying for jobs outside academia, should you submit a CV, a resume, or something in between? Learn how to best organize and present your background and experience for different types of PhD-level nonacademic positions. In part two of the workshop, you will learn how to effectively introduce yourself to potential employers and make the most of your time at the HBC Career ! Fair.

RSVP: If you would like to attend, please send an email to RSVP@thebiotechclub.org with "workshop" in the subject line.

Presented to you by the GSAS Harvard Biotechnology Club (www.thebiotechclub.org) in collaboration with Harvard FAS Office of Career Services-
Healthcare Consulting Panel Discussion
Date: Thursday September 3, 2009
Description: Harvard Biotechnology Club and the Consulting Club at MIT

invite you to a

Healthcare Consulting Panel Discussion

featuring

Clarion Healthcare Consulting
Clearview Healthcare Partners
Decision Resources
The Frankel Group
Health Advances

- Discover career opportunities at the intersection of science, technology, healthcare and business strategy

- Unique chance to learn about exclusively healthcare-focused consulting firms and get recruiting tips

- Hear from consultants about how healthcare consulting is distinct from other types of consulting

Time: Sept 3rd Thursday, 5:30 – 7:00pm Location: Room 270 – Building 3 (Entrance on 77 Massachusetts Avenue) MIT, Cambridge http://whereis.mit.edu/map-jpg?zoom=level2¢erx=710029¢ery=495411&oldzoom=level3&map.x=300&map.y=183

HMS M2 shuttle drops off at 77 Massachusetts Avenue. For M2 shuttle schedule : http://www.masco.org/transit/ptsM2_WeekdaySchedule.htm

Registration is not required but highly appreciated. To register and for any questions regarding the event, please email rsvp@thebiotechclub.org

Dinner will be provided.


Panelist Bios

Steven Chao, Partner, ClearView Healthcare Partners

Steven has 10 years of experience in life science strategy consulting following MD/PhD program. He was most recently VP of Leerink Swann Strategic Advisors and prior to that a Manager at McKinsey and Company, where he led strategic and operations engagements in pharmaceuticals, biotechnology, and payer organizations. Steven has published over 20 articles, and was involved in Neuroscience research in the laboratories of Dr. Lawrence Benowitz and Dr. Jonathan Seidman. He received his BA in Biochemistry from Harvard College, and M.D. and Ph.D. in Neuroscience from Harvard Medical School.

Rob Stolper, Principal, Decision Resources

Robert is a Principal with the Consulting group at Decision Resources, where he has extensive experience in pharmaceutical strategy development, product life cycle planning, and market and technology analysis. Mr. Stolper's work includes later-stage clinical development and commercialization opportunity, as well as assessment of innovative drug development strategies, and spans all key therapeutic markets. He recently led an engagement exploring the opportunities and implications of innovative research in cell-based therapeutics for use in academic, commercial, and clinical settings, and developed set of recommendations for a leading global provider of enabling technologies to guide near- and long-term investments. Prior to Decision Resources, Mr. Stolper was a consultant with ISO Healthcare Consulting (part of Monitor Group), where he led product- and franchise-level strategy development engagements. Mr. Stolper received his A.B. in Biochemical Sciences from Harvard University.

Pushwaz Virk, Consultant, The Frankel Group

Pushwaz joined Frankel Group in 2008 as a Consultant. Since joining, he has worked on a variety of corporate, Technology and Commercialization strategy, Portfolio optimization and L,M&A projects including development of strategy for a Fortune 50 life sciences company to identify, evaluate and invest in early stage technologies, landscape assessment for a biologic in EU, development of M&A strategy for a startup etc. Prior to Frankel Group, Pushwaz was a Management Fellow at Harvard University Health Services and Group Health Plan where he worked on strategic and operational projects in Quality, Finance and Information Technology departments. He also conducted research on international healthcare delivery models at Harvard Business School and developed teaching content on medical tourism. Before joining Harvard, Pushwaz was the Business Development manager at HCL Technologies where he setup the life sciences and healthcare practice of the IT services division and medical process outsourcing business in the BPO division. He practiced as a primary care physician and hospital administrator before moving to the industry. Pushwaz has degree in medicine from Dayanand Medical College India, MBA from University of Delhi, and Masters in Public Health specializing in Healthcare Management from Harvard University.

Marie Schiller, Partner, Health Advances

Marie joined Health Advances in 1998 with extensive experience in the biotech industry. In Marie's more than one hundred client projects at Health Advances, she has focused on guiding management through business and scientific analyses regarding product development, market positioning, portfolio optimization, business development, and corporate strategy. Prior to joining Health Advances, Marie worked at ArQule, Inc. as production scientist in combinatorial chemistry, synthesis, and production. She also worked for GelSciences, Inc., as project scientist in Polymeric Drug Delivery Systems. Marie contributes extensive expertise in protein-based therapies, drug delivery systems, and several clinical areas, including diabetes and autoimmune diseases. Her clients range from early-stage biotech companies to large pharmaceutical companies. Marie graduated magna cum laude with a BA in chemistry from the University of Vermont, where she was also inducted into the Phi Beta Kappa honor society.
XSITE 2009: The Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University.
Date: Wednesday June 24, 2009
Description: High-tech, life-sciences, and energy innovation may well hold the key to the nation's economic health and long-term competitiveness. And as a hotbed of American innovation, New England is poised to become a key driver of economic recovery in the U.S.

This full-day conference will celebrate New England innovation and showcase the panorama of transformative efforts underway in the region in such fields as energy, life sciences, robotics, cloud and mobile computing, and transportation¡Xat universities, startups, and large corporations. At the same time, we plan to challenge New England's innovators to step up and take an even larger role in embracing and shaping the future.

XSITE 2009: The Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University
Wednesday, June 24, 2009
8:00 am - 7:00 pm

SPECIAL BONUSES:
The first 50 paid registrants will be invited to a pre-conference party with Xconomy at the Cambridge Brewing Co. on June 10, 5:30-7:30 pm, and will be eligible to win:
* a $500 gift certificate to No. 9 Park restaurant, courtesy of Atlas Venture
* a 16GB iPod Touch and lunch/iPod tutorial with Xconomy chief correspondent Wade Roush at Legal Seafoods in Kendall Square
* breakfast with Xconomy founder and editor in chief Bob Buderi at Henrietta's Table in Harvard Square and signed copies of his three books
Register now to get a party invite and a chance at the loot: http://xsite2009.eventbrite.com/

CONFIRMED SPEAKERS INCLUDE:
Bob Brown, President, Boston University
Juan Enriquez, Managing Director, Excel Medical Ventures
John Abele, Co-founder, Boston Scientific
Yet-Ming Chiang, Professor of Ceramics, MIT, Co-founder A123Systems
Jeff Nick, Senior Vice President, Chief Technology Officer, EMC
Mohamad Ali, Massachusetts Senior State Executive, IBM
John Maraganore, CEO, Alnylam
Reed Sturtevant, Managing Director, Microsoft Startup Labs
Christina Lampe-Onnerud, CEO, Boston Power
Tillman Gerngross, Co-founder, GlycoFi, Co-founder and CEO, Adimab, Professor of Engineering, Dartmouth
Mick Mountz, CEO and Founder, Kiva Systems
John D. Halamka, Chief Information Officer, CareGroup Health System, Chief Information Officer and Dean for Technology, Harvard Medical School

PRELIMINARY AGENDA: www.xconomy.com/boston/xsite-2009-agenda

MORE DETAILS AND LATEST UPDATES: www.XSITE2009.com

SCHEDULE:
Registration: 7:00 am - 8:00 am
Program: 8:00 am - 5:15 pm
Networking reception: 5:15 pm - 7:00 pm

LOCATION:
BU School of Management, 595 Commonwealth Avenue, Boston, MA

REGISTRATION INFORMATION:
Early Bird Registration (ends June 1): $395
Saver Registration (ends June 15): $495
Regular Registration (ends June 23): $595
On-Site Registration: $650
Student Registration (scholarships available through the Stay in MA program): $95
Press Registration: please e-mail xconomy@schwartz-pr.com
Tickets are transferable but not refundable.

REGISTER NOW: www.XSITE2009eventbrite.com
Forefronts in Bioengineering: Stem Cells, Soft Body Robots, Bio-Optics., hosted by ISPE-Boston
Date: Tuesday June 16, 2009
Description: On Tuesday, June 16 the ISPE Boston Area Chapter will sponsor an educational program entitled "Forefronts in Bioengineering: Stem Cells, Soft Body Robots, Bio-Optics." The presentation will be followed by a tour of the Advanced Technology Laboratories at Tufts. The program will be held at Tufts Gordon Institute, 200 Boston Avenue, Suite 2400, Medford. A networking reception with hors d'oeuvres will take place before the presentation.

Registration: 5:30-6:00pm. Reception: 5:30-6:30pm. Presentation: 6:30-7:30pm. Tour: 7:30-8:30pm.

Members $45; student members $10; non-members $65.

To register online, visit www.ISPEboston.org/events/. For further information, Contact the ISPE Boston Area Chapter office at ISPE@camihq.com or 781-647-ISPE(4773).

The ISPE Boston Area Chapter is comprised of members from regional life sciences companies as well as service providers and equipment manufacturers that support these manufacturing and research operations.

Choosing a lab, hosted by MASS-AWIS and GWIS
Date: Tuesday June 16, 2009
Description: Hosted by: AWIS Massachusetts Chapter AND Graduate Women in Science Boston Chapter

Choosing a lab: tips and advice on how to select a graduate or post-doctoral lab and how to get the best out of it once you are there

Please join MASS-AWIS and GWIS for a discussion on choosing a graduate and post-doctoral lab. Choosing the right research lab can be one of the most important decisions of a scientist's professional life. Come to learn about the simple rules for selecting the perfect lab and how to get what you want (and need) from Graduate School once you join a lab. Feel free to bring questions for the Q&A session after the presentations.

Featured speakers:

Joanne Kamens, PhD - Director of Discovery, RXi Pharmaceuticals, Worcester, MA

Sharotka Simon, PhD ¡V Post-doctoral fellow, Brandeis University, M



When: Tuesday, June 16, 2009, 5:30pm ¡V 8:30pm

Where: Harvard School of Dental Medicine, Research and Education Building
190 Longwood Avenue, BOSTON, MA 02115 (http://www.hsdm.harvard.edu/asp-html/)

Opportunity for networking with our speakers & Refreshments will be served


FOR DIRECTIONS AND MORE INFORMATION, REGISTER BEFORE JUNE 11 AT

http://www.acteva.com/booking.cfm?bevaid=182421

$5 for members and students - $10 for non-members

Join AWIS and/or GWIS to save money on events and to support our work! Go to www.mass-awis.org, www.gwisboston.org, or pick-up a membership form at the event.

Massachusetts Life Sciences Innovation Day
Date: Wednesday June 3, 2009
Description: Massachusetts Life Sciences Innovation Day


"The Survival of the Fittest Life Sciences Companies"



How to survive in the current environment, discover new innovations, identify new markets and raise financing for great products and startups in life sciences in Massachusetts

June 3, 2009
8:00 a.m. - 6:00 p.m.
Sheraton Boston Hotel

The 2nd Massachusetts Life Sciences Innovation Day is the biggest day for life sciences startups and innovation in the State of Massachusetts. Last year this house-full, high-energy, hands-on event brought together legendary speakers and experts to mingle with innovators, post-docs, professors, entrepreneurs, innovators, and venture capitalists. It is the flagship event of life sciences in Massachusetts, jointly and actively put together by all the major organizations that are involved in starting the life sciences startup ecosystem in the Commonwealth.

2009 is the 150th anniversary of the publication of Charles Darwin's On the Origin of Species. As we hope to show you in this program Darwin's theory of evolution may be applied to business and technology development. Alnylam, Genzyme, BiogenIdec, Boston Scientific, Sirtris and Confluent are all companies that have evolved to become major players in the Massachusetts life sciences industry. They all started as basic science theories - in a nurturing environment and with the work of many scientists, engineers and business executives these ideas became new products that have changed global healthcare. At this event we'll talk about how to survive and thrive in both academic and industry research and how to see your ideas be transformed into new products. We'll look at how to Raise money... Change cultures... Chase the best ideas, as well as get a wi! ndow on the future of what's new.

We have an exciting program:

· Listen to fascinating keynote speeches and panels

· Walk around the Innovator's Marketplace where you will find everything you need to start a billion dollar life sciences company

· Meet inventors and entrepreneurs at the poster presentations

· Listen to captivating never-before-discussed panels on the "The Sociobiology of Life Science Cultures" and "Proof of Concept: The Missing Link" where all startup related challenges are explored

· Celebrate the 150th anniversary of "On The Origin of Species" by Charles Darwin" by attending "The Natural Selection of Life Science Start-ups" and "The Evolution of Life Science Technologies"

· Learn from the industry's top investors at the panel "Have the Rules of Getting Investment Changed?"

· Network with the Who's Who of Massachusetts life sciences. Every major stakeholder in the Commonwealth in life sciences is involved in jointly organizing this event - including the major universities, research centers and hospitals


WHO SHOULD ATTEND?
Everyone involved in the life sciences innovation and entrepreneurship ecosystem of MA should attend. This event is designed to inspire researchers, innovators, entrepreneurs, post-docs and graduate students throughout the Commonwealth to take their ideas to commercialization faster - whether it is through management, funding or partnerships. It is an opportunity to meet serial entrepreneurs, venture capitalists, angel investors as well as many top leaders who have created companies or commercialized technologies coming out of laboratories and ideas. The day's event will bring together the Commonwealth's leading researchers and innovators, along with top-tier management of biotech, pharma and medtech companies as well as the key life sciences funding sources including angels, foundations, venture capitalists, grant experts, Federal Government and philanthropists.

WHO WILL YOU MEET?
The day's events will bring together the Commonwealth's leading researchers and innovators, along with top-tier management of biotech, pharma and medtech companies and the key life sciences funding sources including angels, foundations, venture capitalists, grant experts, Federal Government representatives, state elected officials, state program managers, and philanthropists focused on cures. We'll supplement this high-octane group with consultants, lawyers and sector experts who can help you find answers faster.

CONFERENCE FEES
$180 Academics/staff at MATTO member institutions, and Members of MATTO, MBC, Mass MEDIC, TiE, MIT Enterprise Forum, and OPEN.
$225 Non-members
$50 Students and post-docs (ID's will be required at the event)
Research Showcase Poster Presenter - have to apply to present and pay Conference registration fees. Download Poster Presenter Application from the website: http://www.mattcenter.org/malsid2009/home.html
$500 - Innovators' Marketplace Exhibitor (includes two attendees). Service providers will only be allocated space in the exhibit hall if they sponsor the conference - for a listing of sponsorship opportunities please visit our Sponsorship page: http://www.mattcenter.org/malsid2009/sponsorship.html

FOR MORE INFORMATION: Conference Information: http://www.mattcenter.org/malsid2009/home.html

TO REGISTER: Conference Registration: http://register.donahue.umassp.edu/events/one?event%5fid=115949

FOR SPONSORSHIP OPPORTUNITIES
Contact : Abi Barrow, MTTC, at abarrow@umassp.edu
Anupendra Sharma, TiE, at anupendra@yahoo.com

FOR INNOVATORS' MARKETPLACE:
Contact: Pushwaz Virk, Frankel Group, at pushwaz@gmail.com

ABOUT MALSI
Massachusetts Life Sciences Innovation Day has been developed by the Massachusetts Life Sciences Start-up Initiative (MALSI). MALSI is a platform organization that brings together all major public and private entities in the State that are committed to building the next generation of Massachusetts companies. MALSI's mission is to ensure that Massachusetts maintains its lead as the #1 region in the world to start, nurture and grow life sciences companies.

MALSI partners include: Massachusetts Technology Transfer Center, the Massachusetts Biotechnology Council, MassMEDIC, TiE Boston, and several major universities and research hospitals.
Annual Women in Biotech Panel Discussion
Date: Monday June 1, 2009
Description: Harvard Biotechnology Club

presents

The Annual Women in Biotechnology Event

Come and meet distinquished women leaders in the biotech industry and learn about their path to success, what they have learned, and how they have balanced their personal lives with their careers. Our stellar group of panelists includes a venture capitalist, patent lawyer, and executive leaders from biotech/pharma companies.


Panelists

Ellen Baron (Partner, Oxford Biosciences)

Carmen Bozic (Vice President, Biogen Idec)

Pamela Stetkiewicz (Executive Director, Novartis)

Ivana Magovcevic-Liebisch (Executive Vice President, Dyax Pharmaceuticals)



Moderated by Pearl Freier, President of Cambridge Biopartners



Refreshments will be served.



Men are invited and encouraged to attend!

This event is free for all Harvard students and Harvard/Harvard hospital affiliated postdoctoral fellows.

For non-Harvard affiliated attendees, registration is $10 to be paid at the door



To register - rsvp@thebiotechclub.org

Visit our website for more event information

www.thebiotechclub.org

INTELLECTUAL PROPERTY & PATENT LAW PANEL DISCUSSION
Date: Wednesday April 22, 2009
Description:
THE HARVARD BIOTECHNOLOGY CLUB

Presents

INTELLECTUAL PROPERTY & PATENT LAW PANEL DISCUSSION
April 22 (Wed), 2009
5:30-7:00 PM
Bray Room, New Research Building,
Harvard Medical School, 77 Ave Louis Pasteur, Boston, MA 02115

Panel 1: Navigating the licensing and patent hurdles involved in bringing a technology to the marketplace.

Pamela D. Ariniello
Associate General Counsel for Intellectual Property
Dana-Farber Cancer Institute

Vivien J. Tannoch-Magin, Ph.D.
Associate
Hamilton, Brook, Smith & Reynolds, P.C.

Panel 2: Patent Law as a career option for Scientists.

Melissa Hunter-Ensor, Ph.D.
Associate
Edwards Angell Palmer & Dodge LLP

Brenda Danek, Ph.D.
Associate
Finnegan

PIZZA AND DRINKS WILL BE SERVED

*OPEN TO HARVARD AFFILIATED MEMBERS*

Questions? Please email shaila@thebiotechclub.org or visit our website, www.thebiotechclub.org

Harvard Asia Business Conference
Date: Saturday February 14, 2009
Description: There will be a Healthcare Panel at the conference, focusing on how Asia can differentiate itself in biotech/pharma/healthcare industries, which may be of interest to you. The moderator & speakers include the following: Stephen Knight, Managing Director of Fidelity Biosciences (US; moderator); Sam Liao, Head of Business Development & Licensing, Asia of Novartis Vaccines & Diagnostics; Tomoko Ohmae, CEO of PRARD Inc. (Japan); Chi-Huey Wong, President of Academia Sinica (Taiwan).

Additionally, there will be biotech/pharma-focused speakers in other panels, including in the Entrpreneurship panel and the VC panel. It is a good opportunity to get to know the biotech/pharma trend of Asia, as well as how this industry interacts with the Asian governments as well as other for- and non-profit businesses.

For all Harvard students and affiliates including postdocs, fellows, and residents: please register for student rate (see below). Please remember to bring your Harvard ID to the conference.

*****************

The Executive Committee of the Asia Business Conference organized by the Harvard Business School, Harvard Law School, and the Harvard Kennedy School of Government would like to invite future leaders who will make an impact in Asia and the rest of the world to this year's conference. Spanning over 2 days, this year’s conference will be held at the Harvard Business School in Boston on February 14-15, and will feature many leaders in business, government, and the public sector. For participants, the conference will offer unique networking opportunities through a variety of scheduled events.


Please visit www.asiabusinessconference.org for more information and registration details. We look forward to meeting you at the conference.
The 6th annual Healthcare Conference
Date: Saturday January 17, 2009
Description: 6th Annual Healthcare Conference, hosted by the HBS Healthcare Club "Changing Times, Endless Opportunities: Healthcare Innovation, Policy, and Financing." January 17, 2009

SAVE THE DATE!

The 6th annual Healthcare Conference:

"Changing Times, Endless Opportunities: Healthcare Innovation, Policy, and Financing"

Saturday, January 17, 2009

Harvard Business School



Please join us for the 6th Annual Healthcare Conference, presented by the Healthcare Club, Student Clubs of HBS.

Panel topics include venture capital and entrepreneurship, phama/biotech, medical device, payor/provider, personalized medicine, and public health/public policy.

Our featured keynote speakers include:

Ron Williams, CEO of Aetna

Scott Gottlieb, Former FDA Deputy Commissioner

Lonnie Smith, CEO of Intuitive Surgical

Registration available December 2nd at: Healthcare Conference Registration.



Thank you, and we look forward to seeing you in January!

Sincerely,

Joanne Chang & Kristin Myers, Conference Co-Chairs

MIT Enterprise Forum Innovation Series.
Date: Wednesday November 12, 2008
Description: MIT Enterprise Forum Innovation Series. November 12th.

When: Wednesday, November 12th from 6 to 8:30 PM

Where: MIT Stata Building Kirsch Auditorium

Students are free with ID

Pre-registration is encouraged

http://www.mitforumcambridge.org/nov.html

Neuroscience Drug Discovery and Development: The Route to Disease-Modifying Therapies

Disorders of the brain, including neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease and psychiatric diseases such as schizophrenia and depression, pose some of the hardest challenges for the biopharmaceutical industry. Join us for a discussion of how the biopharmaceutical industry is addressing these challenges, with guest speakers from the cutting edge of neuroscience drug discovery.

Speakers:

Darryle D. Schoepp, Ph.D., Senior Vice President and Neuroscience Franchise Head, Merck Research Laboratories

Christoph M. Adams, Ph.D., Chief Business Officer, FoldRx Pharmaecuticals, Inc.

Douglas M. Fambrough, Ph.D., General Partner, Oxford Bioscience Partners

Todd Sherer, Ph.D., Vice President Research Programs, The Michael J. Fox Foundation for Parkinson’s Research

Moderator: Skip Irving, Partner and Managing Director, Health Advances LLC

http://www.mitforumcambridge.org/nov.html

Contact person: Regina Young, reginas@mit.edu
Harvard Biotechnology Club Annual Career Fair
Date: Tuesday November 11, 2008
Description: Are you curious about career options outside of academia?
Are you currently looking for a job?


Harvard Biotechnology Club presents
2008 Career Fair
November 11th, 1-5pm
3rd Floor Rotunda, New Research Building, HMS


Rotunda, NRB (3rd floor)
1:00 - 5:00pm: Recruiting tables
The career fair features biotech, pharmaceutical, patent law, investment and consulting firms.

Firms are looking to recruit applicants with doctoral/medical (PhD, MD, MPH, postdoctoral fellows, residents) and other healthcare/life science degrees. Applicants are encouraged to bring their resumes. Even if you aren’t on the job market come find out more about potential career paths.

Room 217, NRB (2nd floor)
4:00 - 5:00pm: Panel discussion: Exploring Alternative Career Paths in Industry For Scientists

Panelists:
Roopom Banerjee: Vice President, Leerink Swann & Company, Inc.
Michael J. Belliveau, Ph.D., Partner, Clark & Elbing, LLP
Mike DeRidder, Ph.D., consultant, LEK Consulting
Emily Walsh, Ph.D., Program Manager, Alnylam Pharmaceuticals


Join our speakers in an engaging discussion about career opportunities in industry outside the bench and gain insight into their career paths in consulting, program management, investment banking and law.

Moderated by Pearl Freier of Cambridge BioPartners

***
No registration or RSVP is required for attending the career fair.
For Harvard-affiliated/HMS affiliated hospital members attending the career fair: Please bring your Harvard/Hospital ID.

For non-Harvard-affiliated members attending the career fair: we will charge $10.00 at the door.

For questions, please email us : careerfair@thebiotechclub.org

For more information and list of attending companies, please visit: www.thebiotechclub.org/careerfair2008




Panel discussion: Exploring Alternative Career Paths in Industry For Scientists
Date: Tuesday November 11, 2008
Description: Curious about careers in science outside the bench?

Panel discussion: Exploring Alternative Career Paths in Industry For Scientists

November 11th (Tomorrow)

4:00 - 5:00 pm : Room 217 NRB

Join speakers from the biotech industry in an engaging discussion about
career opportunities in industry outside the bench and gain insight into
their career paths in consulting, program management, investment banking and
law.

Panelists:
Roopom Banerjee: Vice President, Leerink Swann & Company, Inc.
Michael J. Belliveau, Ph.D., Partner, Clark & Elbing, LLP
Mike DeRidder, Ph.D., consultant, LEK Consulting
Emily Walsh, Ph.D., Program Manager, Alnylam Pharmaceuticals

Moderated by Pearl Freier of Cambridge BioPartners

Hosted by GSAS Harvard Biotech Club: www.thebiotechclub.org
2008 Life Sciences & Healthcare Venture Summit, hosted by the YoungStartup Ventures.
Date: Thursday October 30, 2008
Description: YoungStartup Ventures will be hosting the 2008 Life Sciences & Healthcare Venture Summit on October 30th, 2008 at Digital Sandbox in New York City.

This exclusive summit will bring together over 350 VCs, Private Investors, Corporate VCs and CEOs of emerging companies. The event will feature 30 Top VCs on interactive panels; 48 cutting edge CEO presentations, and high-level networking opportunities.

Members from the Harvard Biotechnology Club can receive a 10% discount at this event. Please email Joe Benjamin at joe@youngstartup.com to request for ticket discount and indicate that you are a member of the club.

Link to the 2008 website: http://www.youngstartup.com/lifesciences08/index.php


Harvard Biotechnology Club's Power Career Workshop, Oct 30th (Thursday), 2008, 2:30-4:30pm
Date: Thursday October 30, 2008
Description: Harvard Biotechnology Club's Power Career Workshop, Oct 30th (Thursday), 2008, 2:30-4:30pm

Excited about the upcoming Harvard Biotechnology Club Career Fair?

To help you prepare for the Harvard Biotech Club Career Fair on November 11, 2008, Laura Malisheski of the Office of Career Services for Harvard's Faculty of Arts and Sciences, will present two workshops:

CV, Resume, or Something In-Between?
Scientists applying for jobs outside academia are faced with a conundrum... should you submit an academic CV, a one-page resume, or a hybrid of the two? Come to this workshop to learn how best to organize and present your background and experience for different types of PhD-level nonacademic positions.
Thursday October 30
2:30-3:30pm
Warren Alpert Building 341

Networking at the HBC 2008 Career Fair
Not everyone likes to network, but most everyone recognizes that it's an essential part of landing a fantastic job! Come to this workshop to learn how to effectively introduce yourself to potential employers and make the most of the HBC 2008 Career Fair.
Thursday October 30
3:30-4:30pm
Warren Alpert Building 341

RSVP: If you would like to attend either or both of these events, please send an email to RSVP@thebiotechclub.org with "workshop" in the subject line.

Presented to you by the GSAS Harvard Biotech Club www.thebiotechclub.org in collaboration with Harvard FAS Office of Career Services
Moving Your Career Forward in the Biotech and Pharmaceutical Industries
Date: Monday October 27, 2008
Description: Moving Your Career Forward in the Biotech and Pharmaceutical Industries This panel discussion will include scientific leaders and human resources staffing executives from companies including Alnylam, Genzyme, Sirtris, and Vertex Pharmaceuticals to discuss growth opportunities in the industry, employers' perspectives on what makes an attractive candidate, and suggestions for transitioning from academia to industry. Q&A period with the audience to follow the discussion .

*Please note – only pre-registered candidates are invited to attend. Please bring your confirmation number with you to the career fair before 12:30pm to attend. Space is limited, so please arrive early to ensure your attendance.

Confirmed panelists:

Rachel Meyers, PhD, Senior Director of RNAi Lead Development, Alnylam Pharmaceuticals Carolyn Churcher, Senior Director Strategic Staffing, Genzyme Corporation Brian M. Gallagher, Jr. PhD, Director of Strategic Development, Sirtris, a GSK company Lisa Anderson, Senior Director Strategic Staffing, Vertex Pharmaceuticals

For more information, please visit
http://www.biospace.com/jobs/career-fair-detail/?CareerFairId=159

Moderated by: Pearl Freier, Cambridge BioPartners

Contact person: June Salvati, customercare@biospace.com
Harvard Biogen Idec Day
Date: Monday October 20, 2008
Description: Harvard Biogen Idec Day, Monday October 20th 2008

Ever wondered what it would be like to work for a biotech company?

This is your chance to explore the exciting world of biotechnology and learn more about one of the global leaders in the biotech industry. Founded in 1978, Biogen Idec is a key player in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that treat diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Event Details

Date - Oct 20th, 2008
Time - 12pm - 3pm
Location - Bray Room & Pechet Room - New Research Building, Harvard Medical School
41 Avenue Louis Pasteur, Boston 02115

Biogen Idec
Genetown Cafe - Building 6
12 Cambridge Center
Cambridge


Schedule

12pm-12:45pm : Keynote speech by Al Sandrock (Senior Vice President, Biogen Idec)
The keynote speech will address topics such as what is a Biotech company? Biogen Idec's product pipeline, and an overview of therapeutic research areas at Biogen Idec.

12:45pm-1:30pm : Informal networking lunch
Representatives from Biogen Idec Talent Acquisition group will be present to answer questions.

1:30pm-3pm : Panel Discussion with Q&A led by Ken Rhodes (Vice President, Biogen Idec)
The interactive panel discussion will focus on topics related to careers in biotech including diversity of job opportunities in biotech, skills that prospective employers are looking for in applicants and the contrast between careers in academia and industry. Panel participants will be a mix of seasoned and junior Biogen Idec scientists.

4pm-5pm : Biogen Idec Onsite - Networking Cocktail Hour sponsored by Biogen Idec University Relations
Location - Genetown Cafe (Building 6) - 12 Cambridge Center, Cambridge
Don't miss out on this unique opportunity to visit the Biogen Idec campus and interact with Biogen Idec employees including Harvard alums!


There are limited spaces for the event please RSVP at RSVP@thebiotechclub.org with the subject "Biogen Idec" indicating whether you would like to attend the HMS event, the Biogen Idec onsite event, or both. Please include your name, affiliation and position.

Priority for the Networking Cocktail Hour at Biogen Idec facilities will be given to Harvard-affiliated participants.



Presented to you by the GSAS Harvard Biotech Club
www.thebiotechclub.org
Worcester Polytechnic Institute Venture Forum: $15K Technology Business Plan Contest
Date: Friday October 10, 2008
Description: Are you starting a technology-based business
and could use some advice? Are you interested in polishing your presentation skills in front of a panel of potential investors? What about a chance to win $15,000 or more in cash and professional services?
􀁛􀁛􀁛􀁛
If you said yes to any of these questions, then enter the WPI Venture Forum Annual Business Plan Contest.

The WPI Venture Forum Business Plan Contest is open to any technology-based pre-start, startup, and on-going businesses located in the Northeast. Students are welcome. WPI Venture Forum $15K Business Plan Contest entry form and info:
www.wpiventureforum.org

Deadline Submissions: Friday, October 10, 2008. There is a $50 entry fee.
The ISPE Boston Area Chapter presents 2008 Product Show
Date: Wednesday October 8, 2008
Description: The ISPE Boston Area Chapter presents its 2008 Product Show from 12 noon to 8pm at the Gillette Stadium Clubhouse in Foxboro, MA. This event is the biggest one-day gathering of biotech, pharmaceutical and life sciences professionals in the northeast and features educational sessions, 250 exhibitors, career fair, behind-the-scenes tours of the stadium, unlimited networking opportunities, student chapter meeting and a chance to meet special guest, pro football Hall of Famer and former Patriot great, John Hannah. The event - including parking and refreshments - is free for all attendees. For more information and to register online, visit http://www.ispeboston.org/ or call 781 647 ISPE (4773).

The ISPE Boston Area Chapter is comprised of over 1,300 members from regional biopharmaceutical companies as well as service providers and equipment manufacturers that support these manufacturing and research operations.

Should you have any questions, please feel free to contact the ISPE Boston Area Chapter office at ISPE@camihq.com or 781-647-ISPE(4773).

StartUp Opportunities in Life Sciences by Lyon Area Economic Development Agency (ADERLY)
Date: Tuesday September 23, 2008
Description: Join us at the workshop : "StartUp Opportunities in Life Sciences" on Tuesday September 23, 6:30pm

For the full program and to register, or print the invitation attached to this email:
http://www.adgensite-emailing.com/aderly/newsletters/archives/tests/46/2008-07-25_15-39-41.html.

Meet with entrepreneurs, business coaches, representatives of the Lyon bio-cluster to :
- Figure out why and how to start a Tech Venture between the US and France/Europe,
- Get some testimonials by French-American bio entrepreneurs,
- Identify why Lyon ranks #1 in Life Sciences,
- Boost your start-up project with partners, resources and funding opportunities.
- A networking cocktail will follow the workshop.

Hosted at the Genzyme Center, 500 Kendall St, Cambridge on tuesday September 23, from 6:30 to 8:30pm.
Presented by the Lyon Area Economic Development Agency (ADERLY), with the support of the French-American Chamber of Commerce (FACCNE) and the Young Entrepreneurs Initiative (YEi).
Xconomy Forum: How to Build a Life Sciences Company
Date: Tuesday September 23, 2008
Description:
For more information: http://www.xconomy.com/boston/2008/08/19/xconomy-forum-how-to-build-a-life-sciences-company/



Everybody knows that the IPO market is in the doldrums, and that biotechnology and pharmaceutical companies are having their worst year in some 24 years when it comes to developing new drugs. But innovation is messy--and often the best innovations spring from hard times. Today's difficult fund-raising and competitive climate requires creative and flexible approaches to building and sustaining a life sciences company, whether it be in biotech, diagnostics, medical devices, or some other aspect of health care. This conference and networking event features case studies and from-the-trenches stories of new models of innovation---including novel types of collaboration, venture philanthropy, and new approaches to incubation. So, come learn what leading entrepreneurs and life sciences companies are doing to build the next generation of great life sciences companies.
Tech Square Block Party- hosted by New Scientist
Date: Thursday September 18, 2008
Description: New Scientist is hosting a block party for all to attend – particularly geared towards those interested in science and technology. Free food and drinks will be served, and the event will offer science pub trivia, a wii tournament, prizes and giveaways, and the opportunity to network with local science lovers.

More event information can be found at www.tinyurl.com/TechSquareBlockParty. The event is sponsored by Alexandria Real Estate, Charles River Labs, Novartis and Pfizer.



McKinsey & Company presentation at Harvard, September 18, 2008
Date: Thursday September 18, 2008
Description: For Ph.D. students, Post-docs, M.D. students, Interns, Residents, Fellows and Masters students (non-M.B.A.)

*Please note that Masters students should have completed their undergraduate degree before July 1, 2005. If you completed your undergraduate degree after this date, visit www.mckinsey.com/usschools to learn more about our Business Analyst opportunities.



Date: Thursday, September 18, 2008

Time: 6:00 pm - 8:00 pm

Location: Sheraton Commander (George Washington Ballroom), 16 Garden Street, Cambridge, MA, 02138

Campus Map: http://www.mapquest.com/maps?address=16+Garden+Street%2C+Cambridge%2C+MA%2C+02138 Presentation Agenda:

6:00 - 6:30 pm Introduction to McKinsey and our work, overview of recruiting steps

6:30 - 6:45 pm Group Q&A

6:45 - 8:00 pm Reception, McKinsey consultants available for small group and individual discussions (refreshments served)





ABOUT MCKINSEY & COMPANY, AND THE HEALTHCARE PRACTICE:

McKinsey and Company is a global management consulting firm with 89 offices in 45 different countries. We work for 93 of the global Fortune 100 companies, 70 of the US Fortune 100 companies, and over 2000 governments, NGOs, and non-profits across a wide variety of industries, functions, and geographies. About half of McKinsey consultants come from non-business backgrounds, and about half of those are MDs or PhDs. Currently, there are over 850 healthcare-focused consultants at McKinsey, twice as many as 10 years ago.



Within healthcare, our work is extremely diverse in nature and ranges from developing pre-clinical drug discovery strategies for biotechnology and pharmaceutical companies, to helping global non-profits and state governments develop their strategic approach to health crises, to helping large medical centers develop best-in-class clinical quality systems.



Our work is global in nature with projects taking place in offices across North America, Asia, the Middle East and Europe. Consultants often find that they have the opportunity to do work in healthcare in countries outside of the United States if they wish.



Healthcare clients we work with include:

l Global public health entities: Major non-governmental organizations (e.g., The World Health Organization, The Bill and Melinda Gates Foundation, the Clinton Global Initiative, the United Nations), national governments (including China, UK, , leading public health foundations

l Payor/providers: 20 leading academic medical centers, 7 of the 10 largest US hospital systems, governments (e.g., National Health System in the UK), major pharmacy benefit managers,! and 8 of the top 10 managed care systems

l Private equity funds: 19 of 20 top U.S. private equity firms. Participated in 9 of the top 10 European and 7 of the top 10 U.S. buyout deals since in 2006

l Pharmaceutical, Biotechnology, Device and Diagnostic Companies: 19 of the 20 largest pharmaceutical companies. Most of the major biotechnology, device and diagnostic companies



APPLICATION DEADLINE

Application deadline for permanent positions in offices worldwide: September 28, 2008.

Please visit our website for more information and to apply: www.apd.mckinsey.com



If you will be finished with your studies in 2009 you should apply for a permanent position by the deadline above. Medical interns, residents and fellows finishing in 2010 may also apply now, for a permanent position, to receive an early decision. Those finishing studies in 2010 may apply for an internship by December 7, 2008. All others finishing their program at a later date are welcome to attend and learn more for the future. If you will not be applying now, you may register at the same website; registrants will receive e-mails about upcoming events and opportunities.



Please contact your recruiter should you have questions:



Anu Priyadarshi, Recruiter

McKinsey & Company

anu_priyadarshi@mckinsey.com

www.apd.mckinsey.com